Full Report

Figures converted from CNY at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Industry — Auto Manufacturers, Electric Two-Wheelers

1. Industry in One Page

Electric two-wheelers ("E2W" — battery-powered scooters, mopeds, and bicycles ridden as commuter vehicles, not the kick-scooters in airports) are short-distance personal mobility devices. In China, roughly 50 million units a year are sold for $285–$855 each, the same way a household buys a refrigerator — predominantly cash, through neighborhood dealers, replaced every 4–6 years. The industry is a high-volume, thin-margin consumer-durable manufacturing business, not a tech business: gross margins cluster at 15–19%, net margins at 4–8%, and the moats come from distribution density, brand trust on safety, and scale-driven battery sourcing. The newcomer's misconception is that this is "Chinese Tesla for scooters" — it is not. The growth engine is volume replacement under regulatory upgrade cycles, not new technology adoption, and the cycle is set by Beijing's safety standards and city-level usage rules, not by global EV themes.

Takeaway: The arena is a Chinese consumer-durable oligopoly being squeezed by safety regulation and exported to Southeast Asia. Yadea is the volume leader in that arena.

2. How This Industry Makes Money

A Chinese E2W maker buys steel frames, plastic panels, controllers, motors, and — the single biggest cost — batteries; assembles 50,000–100,000 vehicles a day across 6–10 plants; ships them to thousands of independent dealers who resell to commuters and gig workers. The revenue unit is one vehicle, not a subscription. Roughly two-thirds of Yadea's reported revenue is the vehicle itself; about a quarter is batteries and chargers; the remainder is parts. Bargaining power sits at three points: the battery cell supplier (lead-acid or lithium), the dealer (channel access), and the regulator (compliance certification). Yadea internalizes battery production through subsidiary "Huayu" — that integration is the reason scooters and bikes ship with house-brand graphene and sodium-ion packs and the reason batteries are reported as their own ~25% revenue line.

The margin stack is structurally thin. The gross-to-net waterfall on Yadea's FY2025 statement — the strongest year in the dataset — converts 19.1% gross into 7.9% net. AIMA runs slightly higher gross (17.8%), Luyuan lower (13.8%). A single percentage point of gross margin moves operating profit by roughly 30%. That sensitivity is why the chairman's letter spends as much time on "product mix optimisation" as on volume.

3. Demand, Supply, and the Cycle

The 2019–2023 boom was driven by Beijing's 2019 "New National Standard" (新国标), which scrapped tens of millions of non-compliant lead-acid scooters and forced consumers to replace at premium prices — accounting for most of Yadea's 2.7× revenue increase over 2019–2023. When the wave broke in 2024, Yadea unit sales fell 21% and net income fell 52% even as industry volume held above 49 million units. The 2025 recovery (+25% volume, +31% revenue, +129% net income) followed the next regulatory step (post-Nanjing lithium safety rules and the NDRC trade-in subsidy) plus better product mix — the canonical template: safety rules write the demand, premium mix writes the margin.

4. Competitive Structure

The structure is consolidating-oligopoly with a long fragmented tail. Top 5 OEMs hold over half the volume; the next ~100 small factories share the rest and are under regulatory pressure to exit. Within the top 5, competition splits cleanly: Yadea, AIMA, and Emma are mass-market scale players with comparable cost structures and dealer footprints; Niu and Ninebot are premium/tech players competing on margin per unit rather than volume; Luyuan and the long tail straddle mass markets but with lower share. Outside China, the relevant competitive set changes: India is dominated by Ola, TVS, Bajaj, and Ather (Yadea is barely present); Vietnam and Indonesia are where Yadea is investing now; Europe and the US are niche premium markets where Niu and Yadea both compete but neither leads.

5. Regulation, Technology, and Rules of the Game

The 2024 Nanjing residential fire — caused by an after-market lithium battery — was the inflection point for the current regulatory regime. The response, the "Lithium Battery New Regulations," directly raised the R&D-spending threshold (≥2% of sales) and the testing-equipment threshold (≥$143k) needed to qualify as an OEM. Yadea spent $201M / 3.8% of sales on R&D in FY2025; small private OEMs cannot match that. The next reading on whether the consolidation theme is working is the share gain of the top 5 in calendar 2026.

6. The Metrics Professionals Watch

Yadea's FY2025 step-up to 9.8% operating margin and 19.1% gross margin is the structural top of the dataset. AIMA matches on volume and net margin but appears to under-invest in R&D and overseas footprint. Niu has higher unit gross margin (~20%) but loses money operating because SG&A scales as fast as gross profit. The clean read of the peer table: scale + integration + R&D capability dominate this industry, and right now Yadea has all three.

7. Where Yadea Group Holdings Ltd Fits

Yadea is best understood as the Chinese consumer-durables Walmart of E2Ws: lowest delivered cost at the largest volume, with a dealer network too dense to attack and a captive battery line that protects gross margin. It is not the Tesla of this industry — that label fits Niu and Ninebot, which sell fewer, smarter, more expensive units and have not consistently made money. Investors should read the rest of the report through that lens.

8. What to Watch First

A tight checklist of seven signals — each observable from filings, MIIT data, regulators, or transcripts — that would tell a reader whether the industry backdrop is improving or deteriorating for Yadea.

---

Know the Business

Figures converted from Chinese yuan (CNY) at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Yadea is a cyclical, mass-market Chinese consumer-durables manufacturer that happens to make the world's most-sold electric two-wheeler. The business compounds capital at high rates of return when scale, regulation, and product mix all bend its way — and gives most of it back when any one of them turns. The market quotes it at roughly 10× headline earnings, but more than half the market cap is liquid cash and treasury investments, so the operating company is implicitly priced near 6× — pricing in a return to the FY2024 trough, not the FY2025 peak.

1. How This Business Actually Works

Yadea sells one product economically: an electric scooter for a Chinese commuter. The unit price is roughly $324 wholesale ($5,286M / 16.3 million units in FY2025), the customer pays cash at a neighborhood dealership, and the company recognizes revenue at shipment to the dealer. Roughly two-thirds of disclosed revenue is the vehicle, one-quarter is batteries and chargers sold through the captive Huayu subsidiary, and the rest is parts. Incremental profit is almost entirely an operating-leverage story: a 31% revenue increase in FY2025 produced a 119% jump in operating profit because fixed costs ($201M research spend, six research centers, 1,000+ engineers) were already paid for. The same lever runs in reverse — FY2024 revenue fell 19% and net income fell 52%.

The batteries-and-chargers line is the most under-appreciated item on the income statement. It is not a separate business — those batteries go into Yadea's own vehicles, and the segment exists because Yadea built Huayu as a captive cell-and-pack manufacturer. The economic effect is a partial hedge against lithium-cycle volatility and a credible safety claim in a regulatory environment that now requires it. Vertical integration here is defensive, not glamorous: it stops a key supplier from capturing margin, but does not turn Yadea into a battery company.

2. The Playing Field

The right peer set has two unlike halves. Yadea and AIMA are the only profitable scale players in the global electric two-wheeler universe. Ninebot is profitable but earns its money in a different mix (kick-scooters, robots, Segway-branded premium); everyone else — Niu, Ola Electric, Gogoro, Luyuan at the low end of profitability — either loses money or earns single-digit returns on assets. The stock-picking question is whether the market correctly distinguishes Yadea from the money-losing premium-tech crowd.

The signal in the table: Yadea is the only company with all three of scale, profitability, and dealer-network coverage. AIMA is genuinely comparable but trades at a discount of ~15% on P/E and roughly half the P/B — partly because AIMA has been less aggressive overseas, less vertically integrated in batteries, and less generous on dividends. The premium-tech peers (Niu, Ola, Gogoro) are not in Yadea's economic game and should not anchor its valuation. Ninebot looks cheap-ish on margins until you realize a third of its revenue is robotics and shared-mobility, which the market already rewards with a higher multiple (P/E 21.3, P/B 4.2).

3. Is This Business Cyclical?

Yes, deeply — but the cycle is regulatory, not macroeconomic. The 2024 trough was not driven by Chinese GDP or commodity prices; it was the end of a five-year demand pull triggered by Beijing's 2019 New National Standard, which forced replacement of tens of millions of non-compliant lead-acid scooters. When that pull ended, Yadea unit sales fell 21% and net income fell 52% in a single year. The 2025 recovery (+25% units, +129% net income) was triggered by the next regulatory step — the post-Nanjing-fire lithium-battery rule plus a national trade-in subsidy — combined with a deliberate premium-mix shift that pushed ASP up ~10%.

The most important consequence: the cycle is amplified by operating leverage but dampened by the balance sheet. Yadea entered the FY2024 downturn with a large net cash position, paid dividends through it, and emerged with capacity intact. A reader trying to underwrite Yadea must accept that earnings will move ±50% around a normalized line — and then ask whether the current quote prices that volatility correctly.

4. The Metrics That Actually Matter

Five metrics carry the bulk of the story for this business. Four of them — unit volume, ASP, gross margin, and inventory — are read directly from the financials. The fifth — net cash — is structurally important here because it pushes the implied multiple on the operating business much lower than the headline.

ROE deserves a separate note. The 27.8% FY2025 read is not the "earnings power" of this business; it is the cycle-peak reading on a balance sheet that has been growing its cash pile. The structural ROE on the operating business is meaningfully higher — net cash of $1.87B earns roughly nothing while diluting the ratio. The right way to read these returns is to strip the cash, then ask what the operating ROE is. That number is roughly 75% in FY2025 — a remarkable result that the headline ratio understates.

5. What Is This Business Worth?

Yadea is best valued as normalized earnings power times a multiple, plus the cash mountain treated separately. The earnings line is cyclical and not safely capitalized at the peak; the cash line is real, distributable, and currently doing very little. This is not a sum-of-the-parts case — there is one operating business, with one captive battery line that is part of it — but it is a case where the operating business and the financial assets deserve different treatment.

The pragmatic frame: anchor on normalized earnings of ~$0.09 per share, apply 10–13× for a cyclical mass-market manufacturer with structural ROE in the mid-20s, add the ~$0.62 per share of net cash, and a through-cycle value range falls around $1.52–$1.79 per share (≈HK$11.9–HK$14.0 per ordinary share). The stock today (HK$11.27 ≈ $1.44) sits inside that range, biased to the low end — the read depends on whether FY2025 margins prove sustainable or fade halfway back to FY2024.

6. What I'd Tell a Young Analyst

Read the inventory line before the chairman's letter. Yadea's FY2024 collapse was visible in the +33.9% inventory build a quarter before the income statement printed it, and the FY2025 recovery was visible in the +33% YoY revenue at the H1 mark. The dealer channel is the cycle thermometer — and it is reported, just not loudly.

Watch the ASP, not the unit count. Yadea's 16.3M units in FY2025 is only fractionally above the FY2023 peak; the real reason FY2025 net income hit a new high was that ASP went up ~10% on premium-mix migration. If that ASP gain reverses, FY2026 will look more like FY2024 than FY2025 even if volume holds.

Do not pay Niu, Ola, or Ninebot multiples for this business. Yadea is not a premium technology brand. It is the Chinese consumer-durables Walmart of scooters, and its right multiple is closer to a packaged-consumer-goods cyclical (10-14×) than a smart-EV growth story (20×+).

Take the cash seriously. ~44–59% of the market cap is liquid. The market is not pricing it because nobody believes it will ever come out — but the dividend history (40–50% payout) suggests it leaks out at ~5% of equity per year, and a credible move toward a structural buyback or higher payout is the mechanism that would force the market to value the cash explicitly. The variant-perception read is that the next-leg dividend or buyback cadence resolves whether the discount stays or compresses.

Don't ignore family control. The Dong/Qian family owns ~63%. That is a stability anchor — they have not levered the balance sheet, have not chased fads, and have not abused minorities — but it also caps the probability of aggressive acquisitions, hostile takeover, or activist-driven cash returns. Underwrite the business assuming it stays family-run, conservatively financed, and dividend-paying.

And finally: track Beijing, not the showroom. The next leg of consolidation (and Yadea's share gain) depends entirely on whether the 2024-25 lithium and standard-conditions rules drive the long tail of ~80 small OEMs out. That is the single observable variable that would justify a higher multiple on the operating business.

---

Figures converted from CNY at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Long-Term Thesis — What Has To Be True Over the Next 5–10 Years

1. Long-Term Thesis in One Page

The long-term thesis is that Yadea spends the next decade as the cash-generative scale incumbent of a structurally consolidating Chinese consumer-durables oligopoly that is being slowly, partially exported into Southeast Asia — and that the controlling family chooses to surface the $2.47B cash pile rather than hoard it indefinitely. This is not a long-duration compounder unless three things happen together over five-to-ten years: (a) the post-2024 Standard Conditions and lithium-safety rules drive the ~80 small private OEMs out, lifting top-five share from ~50% toward 60%+ and giving Yadea durable mid-cycle gross margins in the 16–18% band; (b) Vietnam, Indonesia, and broader Southeast Asia replicate the China dealer playbook well enough to move international revenue mix from ~5% toward 15–20% by FY2030; and (c) the Dong/Qian family converts the cash pile from a stranded asset into a sustained 50%+ payout-ratio regime, with periodic specials or a real buyback authorization. If those three converge, the operating business compounds at 8–10% revenue with ~22% normalized ROE on operating equity, and the cash returns close the AIMA-to-Yadea multiple gap. If they don't, this is a cyclical OEM at a fair multiple with a permanently-discounted cash hoard — a 7% total-return name, not a compounder.

2. The 5-to-10-Year Underwriting Map

A small number of durable drivers carry the multi-year case. Each must be observable and each must have both a validation and a refutation signal. Cycle-print details, near-term inventory swings, and quarter-to-quarter ASP wiggle live in the technicals and short-interest pages; this table is the long-duration scoreboard.

The driver that matters most is capital-return regime change. The other five drivers determine the operating-business multiple, but the cash pile is what currently makes the headline P/E misleading: at the FY2025 print, ~58% of market cap was inert net cash earning roughly 2%. Until a credible, repeatable payout-ratio floor or buyback program emerges, the operating business will trade at AIMA-discount levels, the multiple gap won't close, and the durable consolidation thesis will be expressed mostly as dividend yield, not as a re-rating. If the family chooses to compound the cash inside the trust forever, the long-term thesis becomes simply a ~7% dividend yield with optionality — fine, but not a compounder. The single largest 5-year delta is whether the FY2025 special was the start of a regime or a one-off sweetener.

3. Compounding Path

Yadea's compounding math is unusual because the operating business is a 22-27% ROE franchise sitting on top of a balance sheet that holds half its assets in cash and treasury investments. The right way to read multi-year compounding is to separate (i) operating-business growth + margin + cash conversion from (ii) cash-pile policy. Both have to work for the equity to compound at the rates the cash, ROE, and market position suggest are achievable.

The history shows a 7-year revenue CAGR of ~17.5% ($1.72B → $5.29B) and a ~28% NI CAGR but with an FY2024 trough that cut earnings in half. The right way to underwrite the next 5–10 years is to discount the cyclical extremes and ask what the through-cycle picture supports. The table below frames a base case for FY2030 with the assumptions made explicit; this is a thesis-scoping exercise, not a forecast.

The compounding map sums to a base-case 8–14% IRR over a five-year window — a decent, not spectacular, return — with the dispersion concentrated in two variables: mid-cycle operating margin (whether the FY2025 step-up reverts to FY2022–23's 7–8% band or to FY2024's 5.9% trough) and capital-return policy (whether the cash pile stays static or starts to drain). The reinvestment runway is real but bounded — Yadea has ~5 years of overseas plant build to fund, but China capex intensity is already low. The lever for outsized compounding is on the capital-return side, not the reinvestment side; that is the unusual feature of this thesis.

4. Durability and Moat Tests

A 5-to-10-year position requires the moat to survive things the FY2025 print did not test. Four tests carry most of the weight — one each on the competitive, regulatory, technology, and financial axes. Each has a current-evidence reading, a multi-year validation signal, and a refutation signal.

The competitive test (Yadea vs AIMA on operating margin) is the cleanest binary — it can be checked from publicly-reported interim and annual results. The financial test (cash conversion ex-bills-payable) is the one the forensic page flagged: the FY2025 print is forensically supportable but the working-capital composition matters more than the headline. If both of those go Yadea's way over FY2026-28, the thesis upgrades from "narrow moat surviving" to "narrow moat widening." If either reverts, the moat call holds but the multi-year upside compresses to the dividend yield. The regulatory test is necessary but is shared with AIMA — it lifts both companies, not just Yadea.

5. Management and Capital Allocation Over a Cycle

The Dong/Qian founder pair has run this business for 25 years and through the public-market history since 2016, so the capital-allocation track record is observable rather than inferred. The pattern is consistent and gets stronger with cash generation: pay a dividend, fund a moderate capex cycle, do small bolt-on M&A, do not lever, do not chase fads, do not abuse minorities. There is no transformational M&A, no leveraged growth, no dilutive issuance, and no related-party self-dealing of consequence. Within the universe of founder-controlled HKEX-listed Chinese consumer companies, this is on the better side of the ledger — but the structural ceiling on the thesis is that 63% control means minority shareholders have no practical lever to force a capital-return regime change.

Two facts about management deserve emphasis for a multi-year view. First, the FY2024 dividend was protected through the trough — that is the kind of behavior that distinguishes a steward from an operator, and it is the evidence base for trusting the FY2025 +45% dividend hike as a regime signal rather than a one-off. Second, the FY2025 buyback of $7M against a market cap of $4.3B and an EV/EBITDA of ~3× is the single clearest sign of capital-allocation conservatism: if the family genuinely viewed the operating business as cheap, the buyback would be an order of magnitude larger. The PwC-to-Deloitte auditor swap (56 days after AGM reappointment) is the single open question that limits how much credibility a multi-year thesis can extend to management; a clean Deloitte FY2026 audit is the necessary precondition for any thesis upgrade.

6. Failure Modes

Three failure modes are real and observable, two are tail risks that warrant specific monitoring, and one is the catch-all "what if I am wrong" backstop. Each maps to early-warning indicators that would surface before the thesis breaks in the equity.

The single most consequential failure mode is #1 — permanent cash discount. It is the failure mode where the operating business does fine (revenue compounds at 7-10%, ROE stays in the 20-25% band) but the equity does not compound because the multiple gap to AIMA never closes. The bear case from short-interest desks is a layered version of #2 (cash flow quality) plus #6 (governance shock). The thesis breaker that is hardest to anticipate is #5 (premium-tech entrant) because Ninebot's H1 2025 growth was already abnormal and the trade-press narrative shift from Yadea-as-leader to Yadea-as-defender is a real market signal.

7. What To Watch Over Years, Not Just Quarters

Five multi-year milestones carry most of the long-term-thesis decision weight. Each is observable from public disclosures, each has a defined time horizon, and each has a defined validation/refutation pair. These are not catalysts in the trade-the-print sense; these are the milestones that move the underwriting case.

---

Figures converted from CNY at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Competition — Who Can Hurt Yadea, Who Yadea Beats

Competitive Bottom Line

Yadea's moat is real but narrow and asymmetric. The dealer-network density, the captive Huayu battery line, and the 16.3 million-unit scale together let Yadea earn $416M at a 19.1% gross margin while every Chinese rival except AIMA either earns less, loses money, or grows in an adjacent product set. The competitor that matters most is AIMA, not the premium-tech crowd: AIMA runs the same playbook at ~75% of the volume, out-earned Yadea in the FY2024 trough ($272M vs $174M net income), and trades on a higher P/E (12.0× vs Yadea's headline 10.2×). The investable question is whether Yadea's lead over AIMA on overseas plants, battery integration, and R&D ratio (3.8% of sales) is widening or narrowing — and on most of the FY2025 evidence it is widening, but it is still a duopoly fight, not a one-horse race.

The Right Peer Set

The peer set has three logical clusters. Mass-market scale — AIMA is the only genuine economic substitute. Premium / smart-tech — Niu and Ninebot compete on a different price point and product mix; relevant for valuation framing but not for share. Strategic international — Ola Electric defines what competition looks like in Yadea's #1 expansion market (India), and Luyuan is the next-closest HKEX-listed peer for accounting comparability. Gogoro is included only for multiple triangulation because it is one of very few listed pure-play EV two-wheeler names globally; its battery-as-a-service business model rules it out as a product competitor.

The bubble chart makes the asymmetry visible: two players — Yadea and AIMA — sit in the top-right (scale + profitable). Ninebot earns a comparable margin on a much smaller revenue base because half its business is robotics and premium kick-scooters, not the mass-market two-wheeler that defines Yadea's economics. Everyone else either loses money (Niu, Ola, Gogoro) or earns Luyuan's anemic 2% net margin at a fraction of the scale. The market awards Ninebot the highest multiple in the set ($4.58B mkt cap on $1.94B revenue), reflecting that its profit pool is partially tech-flavoured. Yadea sits at the largest revenue with a market cap below Ninebot's — the structural undervaluation read.

Where The Company Wins

Four advantages are observable in the data rather than just claimed in the chairman's letter.

1. Volume scale and unit economics. Yadea shipped 16.3M units in FY2025, roughly 1.7× AIMA, 2.8× Ninebot's E2W output, and ~45× Ola Electric. The single most telling comparison: Yadea's revenue per unit is ~$324 wholesale (mass-market) but its FY2025 gross margin (19.1%) is two points above AIMA's FY2024 (17.8%) and five points above Luyuan's (13.8%). Mass scale + better gross margin in the same product category is the cleanest signal that Yadea has cost leadership inside the value tier. Industry source: Yadea FY2025 AR + Frost & Sullivan 22% global share claim.

2. Dealer network density. Yadea operates 5,122 distributors and 40,000+ retail outlets in China; AIMA discloses a comparable footprint, Luyuan less, Niu and Ola fundamentally smaller (Niu store-only, Ola direct-to-consumer 4,000 touchpoints). Replicating Yadea's dealer count would take a decade and is the single hardest barrier facing premium-tech entrants. Niu's revenue is 12% of Yadea's despite a stronger international brand precisely because it cannot match Yadea's neighborhood-dealer access to mass Chinese commuters. Industry source: Yadea FY2025 AR; Niu/Ola annual report MD&A.

3. Captive battery vertical integration via Huayu. $1.29B (24.4%) of Yadea's FY2025 revenue is its in-house battery and charger line — sodium-ion went into mass production in Jan 2025 — and the strategic effect is a partial hedge against cell-supplier margin capture. AIMA, Luyuan, Ola, and Niu source batteries from outside vendors (CATL, Tianneng, Chaowei). Only Ninebot and Gogoro run comparable in-house battery operations, and Gogoro's swap network is a different business model. In a regulatory regime (2024 Lithium Battery Safety Rule) that prices safety into the unit, Yadea's certified in-house pack is a moat that is mechanical, not narrative.

4. R&D intensity above the regulatory floor. Yadea spent $200M (3.8% of sales) on R&D in FY2025 — comfortably above the MIIT's 2% mandatory minimum under the 2025 "Standard Conditions" rule. AIMA's disclosed R&D was $94M (3.2% of FY2024 sales); Luyuan $27M (3.7% of FY2023 sales); Niu $24M (3.9% of FY2025 sales) but on a tiny revenue base. The relevant peer comparison is absolute spend: Yadea outspends AIMA on R&D by ~2×, and outspends Luyuan/Niu by ~7×, which is what funds the 6 R&D centres, 1,000+ engineers, and 2,000+ patents.

Where Competitors Are Better

Four real weaknesses; none is existential, but each is what an honest competitive read has to acknowledge.

1. AIMA out-earned Yadea in the FY2024 downturn. When the New National Standard pull faded, AIMA's net income grew +5.7% to $272M while Yadea's collapsed -52% to $174M. AIMA's FY2024 net margin (9.2%) sat above Yadea's (4.5%). AIMA also extended the lead into H1 FY2025 with +23% revenue and +27.6% net profit growth — matching Yadea's recovery while showing it can run a leaner cost base. The narrative that Yadea is "the global #1" obscures that AIMA earns more per unit of revenue in adverse conditions — a structural read that AIMA's lighter overseas footprint and lower R&D burden translate into higher trough-cycle profitability.

2. Ninebot is growing nearly 2× faster. Ninebot's +38.9% FY2024 revenue and +81.3% net income growth dwarf Yadea's -19% / -52% from the same year. Ninebot's product mix (robotics, kick-scooters, premium e-scooters) catches the smart-mobility-tech reward the market is pricing in via a 21.3× P/E versus Yadea's 10.2× — a ~2× multiple premium. If the long-term consumer migration in China is toward smart, connected, lithium-only E2W rather than commodity mass-market scooters, Ninebot's product mix is positioned for that move, and Yadea's is not. Yadea's 19.1% FY2025 gross margin already captures the premium-mix lift; Ninebot's is structurally higher.

3. Niu's international brand is genuinely stronger than Yadea's. Niu's overseas revenue is 13.4% of sales — Yadea's is ~5% — and Niu has had a meaningful European presence for years (EU homologation, lifestyle marketing). When investors compare brand strength in EU, Niu wins. The catch: Niu loses money operating (FY2025 op margin -2.0%, net margin -0.9%), so the brand has not translated to economics. But for Yadea's overseas thesis (Southeast Asia + Europe expansion), Niu is the existing premium incumbent that Yadea's lower-priced products must displace, not the other way around. Source: Niu FY2024 MD&A; Niu IR press releases.

4. Ola Electric blocks Yadea's India entry. India is Yadea's #1 long-term international target, and Ola is the local incumbent with 30% market share (down from 35% in FY2024 — share is going to Bajaj and TVS, not Yadea). Ola is also vertically integrating with its own Bharat Cell production. India's PLI scheme + FAME-II legacy creates structural cost advantages for local OEMs. Yadea has effectively no installed base in India and is competing against three large local-incumbent ICE-pivot motorcycle OEMs (Bajaj, TVS, Hero) plus Ola — far harder than Vietnam or Indonesia, where there is no established local champion. Source: Ola Electric FY2025 AR MD&A; Vahan registration data referenced therein.

Threat Map

The threats are scored on a 24-month horizon. High means the threat is already pressuring Yadea's economics; Medium means visible but not yet quantifiable in the financials; Low means structural backdrop, not actionable share loss.

Moat Watchpoints

Five measurable signals that would tell an investor whether Yadea's competitive position is widening or narrowing — each observable from public filings, MIIT data, or quarterly disclosures.

---

Figures converted from CNY at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Current Setup & Catalysts

1. Current Setup in One Page

The stock is currently trading at US$1.44 — the 14th percentile of its 52-week range — and the market is mostly watching whether the H1 2026 interim print (board meeting expected the last week of August) repeats H1 2025's blowout (revenue +33%, net profit +59%, gross margin 19.6%) or confirms the bear's call that FY2025 was a subsidy-and-working-capital peak. The recent setup is Mixed-to-Bearish: management delivered exactly what they promised on FY2025 (revenue $5.29B / +31%, net profit $416M / +129%, US$0.068 final dividend) and the market faded the print — shares are −6.3% since the 27-Mar-2026 results, the 50-day sits below the 200-day in a fresh death-cross regime, and SFC reportable shorts have rebuilt to 140.4M shares (highest since Q2 2025). The two market focus items inside the next six months are (i) the H1 2026 interim cash-flow statement (will bills-payable contract? will the new supplier-finance programme grow?), and (ii) the 17-Jun-2026 AGM (renewal of the share-issuance mandate and the Deloitte re-appointment vote). The H1 2026 print is the only catalyst that can credibly resolve the bull-vs-bear debate before year-end; everything else is incremental.

2. What Changed in the Last 3-6 Months

The recent setup is shaped by a tight cluster of events between January and April 2026: the FY25 profit alert, the Vietnam plant opening, the FY25 annual results, the Deloitte FY25 audit clearance, and the announced INED departure. None individually crystallised the thesis; collectively they tested both bull and bear cases and the tape concluded with shares back near the bottom of the 52-week range.

Narrative arc. Through Q3 2025 investors cared about whether the FY25 cyclical rebound was real (the answer: yes, headline). Through Q4 2025 and Q1 2026 they cared about whether it would clear an unmodified Deloitte audit (the answer: yes, on schedule, 30-Mar-2026). What they care about now — late May 2026 — is whether the cash-flow plumbing under the FY25 print holds up in H1 2026 without further bills-payable expansion, and whether the controlling family will produce a second consecutive year of >=50% payout-ratio capital return or revert to the FY24 base. Neither question can be settled before the late-August interim print. The unresolved overhang is governance succession: the audit-rotation pattern, the worst-decile ISS QualityScore, and the announced INED departure mean that even a clean operating result will leave a structural discount until the family produces a real Audit Committee chair succession plan and a buyback authorization with size.

3. What the Market Is Watching Now

The live debate is narrow. Bulls and bears agree on the FY25 print, the cash pile, the dealer footprint, the Vietnam plant, and the long-term consolidation thesis. They disagree only on whether the H1 2026 cash flow holds together without further bills-payable expansion and whether the family converts the $2.47B cash pile into a real capital-return regime. Both of those questions get partial answers in the next 90 days (AGM mandate + dividend payment) and full answers in the late-August interim print.

4. Ranked Catalyst Timeline

Dates are anchored to verified HKEX disclosures or known Hong Kong-listed cadence (H1 interim board meeting typically falls in the last week of August based on the 26-Aug-2025 precedent). Ranking is by expected decision value, not chronology — the AGM is closer in time but resolves less of the underwriting debate than the late-August interim print.

5. Impact Matrix

Three catalysts in the six-month window update durable thesis variables; the rest add information without changing the underwriting case.

The impact matrix concentrates the decision weight on three items. Catalyst #1 (the H1 2026 print) and Catalyst #2 (the AGM capital-return signal) together resolve roughly two-thirds of the institutional debate. Catalyst #3 (the NDRC implementation rules) is the largest swing factor for sell-side FY26 estimates — a near-term consensus driver, not a multi-year thesis driver. Catalysts #4 (governance succession) and #5 (AIMA comparison) are durable updates that change the underwriting multiple. Catalyst #6 (SPR direction) is the implementation-side tell — it does not update the thesis but it telegraphs how the institutional book is reading the same evidence.

6. Next 90 Days

7. What Would Change the View

Three observable signals over the next six months would most change the investment debate. First, the H1 2026 cash flow statement — specifically, whether bills payable contracts (or stays flat) and whether the supplier-finance outstanding balance declines or holds steady. A clean H1 2026 CFO/NI ratio above 1.0× without further working-capital release would validate the Long-Term Thesis driver #2 (mid-cycle margin uplift) and refute the bear's Failure Mode #2 (cash-flow quality fails). Second, an AGM or post-AGM buyback authorization with size — a >=$143M buyback program, or a second special dividend declared with the H1 2026 interim, would be the first observable evidence that the controlling family is committing to a sustained 50%+ payout regime rather than a one-off FY25 sweetener. This is the single multi-year signal that converts Yadea from a dividend-yield trap into a capital-return compounder. Third, an explicit Audit Committee chair succession announcement — given the PwC-to-Deloitte swap, the Wong Lung Ming departure, and the worst-decile ISS QualityScore, a credible chair successor with public audit credentials would be the first material reduction in the governance discount that limits the entire long-term thesis. None of these signals alone fully resolves the underwriting debate, but any two together would force the multi-year case to update; their joint absence after the late-August interim print would confirm that Yadea remains a narrow-moat cyclical at a fair multiple with a permanently discounted cash hoard — exactly the bear's "yield-trap" failure mode.

---

Figures converted from CNY at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Bull and Bear

Verdict: Lean Long, Wait For Confirmation — the valuation gap and capital-return inflection are too sharp to dismiss, but the auditor change and cash-flow-quality questions require one print to clear. The bull's strongest argument is mechanical: $2.48B of net cash (58% of market cap) leaves the core operating business at ~3.4× EBITDA versus AIMA at 7.8×, and the FY2025 dividend already jumped +245% YoY with a special dividend declared. The bear's strongest argument is structural quality: $211M of new supplier-finance discounting and $328M of bills-payable expansion explain most of the CFO swing from $41M to $856M, and a second Big Four resignation in five years is not a coincidence. The decisive variable for both sides is the same: the H1 2026 interim print (August 2026) on bills-payable trajectory and gross margin persistence. The durable thesis variable is whether the cash actually leaves the balance sheet — that is what would force a re-rating regardless of any one quarter.

Bull Case

Bull's reference value is around US$2.18 on a peer-anchored sum-of-parts: 6.0× EV/EBITDA on ~$650M FY2026E EBITDA (still below AIMA's 7.8×) plus $2.55B net cash, cross-checked by $0.092 normalized EPS × 13× + $0.84 net cash/share — a scenario value, not a forecast. Timeline 12–18 months, anchored to the H1 2026 interim (August 2026) and FY2026 final (March 2027). The disconfirming signals are gross margin below 16% in H1 2026, bills payable above $1.63B, and no further capital-return signal by August 2026 — any two of those three would push Bull aside.

Bear Case

Bear's downside reference is around US$0.96, built from ~$203M normalized through-cycle NI × 7× P/E = $1.42B operating value, plus $2.48B net cash discounted 35% ($1.61B) for stranded-cash + family-control + governance overhang = $3.0B equity, rounded to $2.95B — a scenario, not a forecast. Timeline 12–18 months. The cover signal is a clean Deloitte FY2026 audit (no expanded KAM on revenue or cash-flow classification) plus a contracting bills-payable book plus an explicit ≥$430M special dividend or structural buyback authorization — all three together would refute the cash-quality, governance, and stranded-cash legs simultaneously.

The Real Debate

Verdict

Lean Long, Wait For Confirmation. Bull carries more weight on the math — a 3.4× EBITDA core operating business with 58% of market cap in net cash, a +245% dividend jump, and a regulatory consolidation rule that quantifiably removes ~80 small OEMs is a setup that almost never coexists at a global volume leader. The single most important tension is whether the $2.48B cash actually leaves the balance sheet, because that is the only mechanism that closes the gap to AIMA's 7.8× — the operating-leverage story is real but not load-bearing without the capital-return regime change. Bear could still be right because two Big Four resignations in five years, a 25.7% rebuild in SFC shorts, and a CFO line that reverts to 1.13× CFO/NI when you strip bills-payable and supplier-finance discounting are not noise — if the next interim shows bills payable above $1.6B and gross margin below 17%, the +245% dividend was a sweetener for a quality stock that is not actually a quality stock. The durable thesis breaker is the FY2026 capital-return regime — a second special dividend or ≥$430M structural buyback authorization confirms the variant-perception read; absence does not. The near-term evidence marker is the H1 2026 interim print (August 2026) on bills-payable trajectory and gross-margin persistence — that is when the cash-flow-quality and subsidy-peak debates resolve in one document.

---

Figures converted from CNY at historical FX rates — see data/company.json.fx_rates. Ratios, margins, multiples, unit counts, and percentages are unitless and unchanged.

What, If Anything, Protects Yadea From Competition

1. Moat in One Page

Conclusion: Narrow moat. Yadea has a real, evidenced, hard-to-copy advantage in the Chinese mass-market electric two-wheeler ("E2W" — battery-powered scooters and mopeds bought as commuter transport) industry. The advantage rests on three load-bearing pillars: (a) a 16.3 million-unit annual volume that is larger than the next twenty E2W brands in the world combined and ~1.4× its only profitable scale rival, AIMA, (b) a 5,122-distributor / 40,000-retail-outlet Chinese dealer footprint that would take a decade and several billion dollars to replicate, and (c) a captive battery line through subsidiary Huayu that supplies ~24% of revenue in-house and shipped sodium-ion packs into mass production in January 2025. The weakness is equally clear — AIMA out-earned Yadea on net margin in the FY2024 trough (9.2% vs 4.5%) and matched it in H1 FY2025, which means the moat protects Yadea against the long-tail and the premium-tech crowd, not against its single most credible peer. A reasonable read on the evidence is that Yadea sits at the top of a consolidating oligopoly, not at the top of a winner-take-all market.

The clean three-line summary: the moat exists, it has shown up in returns and share, and it has survived a 2024 trough — but it is a duopoly moat, not a monopoly moat, and the second player matches Yadea on profitability today.

2. Sources of Advantage

A moat source has to be company-specific (not just an attractive industry), evidenced in numbers (not just claimed), and defensible against a well-funded copycat. Six candidates pass partly; the table separates which protect Yadea's economics today versus which are at risk of being copied.

3. Evidence the Moat Works

A moat that exists on paper but never shows up in the numbers is no moat. Six pieces of evidence from filings, peer comparisons, and external research; the table reads each piece honestly — some support the moat, two complicate it.

ROE has averaged ~25% across seven years and never fell below 14.5% (the FY2024 trough). For a Chinese consumer-durables manufacturer, that is a high-quality return profile — but the moat reading is cleaner from gross margin (the operating-side proxy for cost advantage) than from ROE (which is flattered by the cash pile). Gross margin held at 15.2% in the trough and recovered to 19.1% in FY2025 — that two-direction durability is what a moat looks like in the income statement.

4. Where the Moat Is Weak or Unproven

Four real weaknesses. None disprove the moat, but each constrains how wide it can be called.

Weakness 1 — AIMA matches the dealer footprint and out-earns Yadea on net margin. This is the single most important honest data point in the file. AIMA's FY2024 net income ($273M) beat Yadea ($174M) in the trough year; AIMA's H1 FY2025 net income grew +28% YoY against Yadea's +60%, but AIMA started from a higher base and remains a more profitable operator per dollar of revenue. AIMA spends less on R&D, has less overseas exposure, and runs a leaner cost base — which is either a strength (margin discipline) or a weakness (under-investing for the future), depending on which side of the moat thesis you sit on.

Weakness 2 — Brand is shared, not exclusive. Daxue Consulting's 2024 consumer survey places Yadea among the top-3 most-mentioned Chinese E2W brands — but the three are Yadea, AIMA, and Lvyuan, with NIU 4th. Yadea's brand reduces customer-acquisition cost; it does not lock in pricing power above the closest peer. The FY2025 ~10% ASP increase is the only hard evidence of pricing power, and it depended on a trade-in subsidy programme that pulled customers up-tier — not pure brand pull.

Weakness 3 — International moat is unproven. Overseas revenue is ~5% of total. Yadea has 10 overseas plants (more than any listed peer), but the local-market positions are immature: in India, Ola/Bajaj/TVS/Hero hold ~85% share collectively and the PLI/FAME-II scheme structurally favours local OEMs; Niu has 13.4% international revenue mix and a better EU brand. The "China playbook exported to SE Asia" thesis is a 5-year option, not a current moat — and the option premium for the optionality is small because the proof points are minimal.

Weakness 4 — Commodity product economics limit how high gross margin can ever go. Even at the FY2025 cycle peak, Yadea earns a 19.1% gross margin — below any high-quality consumer-staples or branded-durables business. The ceiling is set by battery cell cost (40-55% of bill-of-materials) and by the mass-market price point ($290-430). No amount of brand, scale, or integration moves a $324 commuter scooter into the gross-margin territory of a luxury durable. The moat protects share and returns at the current margin level; it does not unlock a higher margin level.

5. Moat vs Competitors

Read this table as the moat-vs-moat comparison, not the financials-vs-financials comparison (that is in the Competition tab). Each peer is scored on the moat source where it matters most.

The heatmap makes the central point visually: Yadea leads on scale, distribution, integration, and R&D capacity — the mechanical moat sources. It does not lead on premium brand (Ninebot, Niu) or on trough profitability (AIMA, Ninebot). The competitor that matches Yadea on the most moat dimensions is AIMA (4/5 on dealer density and scale, 5/5 on trough margin); the competitor that scores high on moat dimensions Yadea cannot easily copy is Ninebot (premium-tech brand + Xiaomi ecosystem + international).

6. Durability Under Stress

A moat only counts if it survives stress. Six stress cases; each was either tested in the historical record or is the next plausible test on the horizon.

The stress table reads consistently: the moat has been tested twice (the FY2024 regulatory trough and the historical price-clearance episodes) and held. It has not yet been tested by the next plausible stresses (subsidy taper, sodium-ion adoption curve, India entry, founder transition). The moat is therefore proven against the stresses Yadea has actually faced, and unproven against the stresses it has not yet faced. That is the honest read on durability.

7. Where Yadea Group Holdings Ltd Fits

The moat does not sit evenly across the business. The right segmentation:

The clean read: roughly 72% of Yadea's revenue (e-scooters + e-bicycles) sits inside a strong moat in the China mass-market value tier. ~24% (the captive battery line) sits inside a moderate moat that depends on external cell pricing dynamics. ~5% (international) is moat-optionality, not moat. The premium tier is moat-less for Yadea but Yadea's strategy does not depend on capturing it. The moat is real where 72% of revenue is, which is more than enough to underwrite returns at the current valuation.

8. What to Watch

Six measurable signals — each observable from filings, MIIT monthly data, or peer disclosures — that would tell an investor whether the moat is widening, holding, or fading.

---

Financial Shenanigans

Figures converted from CNY at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Yadea earns a Forensic Risk Score of 48 (Elevated). The numbers are not obviously distorted, but three forensic signals fire at once on the FY2025 result: an unexplained Big-Four auditor swap (PwC out, Deloitte in) eight months before the FY2025 audit closed, the introduction of a new supplier-finance programme that already routed $211M of bills through banks while keeping the cash settlements inside operating cash flow, and an operating cash flow that swung from $41M to $856M almost entirely on a $328M build in bills payable. None of this is fraud — it is aggressive working-capital and presentation management in a +129% rebound year under tight founder control. The single data point that would most de-risk the grade is the FY2026 interim cash flow: if CFO/NI stays above 1.0× without further bills-payable expansion, most of the elevated risk converts to "watch."

The Forensic Verdict

Shenanigans scorecard — 13 categories

The scorecard gives three reds (supplier finance, working-capital CFO, plus breeding-ground via the auditor swap covered in §2), six yellows, and five clean negatives. The reds cluster around cash-flow presentation, not revenue or earnings — Yadea's income statement is broadly defensible, but the cash-flow statement is doing more presentational work than the surface 2.06× CFO/NI suggests.

Breeding Ground

The governance environment dampens external challenge to aggressive choices. Yadea is founder-controlled, family-managed, and the audit relationship was reset mid-rebound.

The PwC-to-Deloitte rotation is the single signal a forensic reader cannot wave away. PwC accepted reappointment on 17 June 2025, walked away 56 days later, and Deloitte stepped into the casual vacancy in September. Yadea's published rationale is generic ("current business situation and future needs of audit services") and neither auditor has flagged a disagreement. In a vacuum that wording is HKEX-standard boilerplate; in the context of a +129% profit rebound, a brand-new supplier-finance programme, and a $328M bills-payable build, the timing is conspicuous. The compounding signal is the audit fee falling 11% year-on-year against a balance sheet that grew 22% — auditor-change years usually carry a fee bump, not a cut. Wong Lung Ming's announced 2026 resignation makes this three governance changes in eighteen months.

The breeding ground does not prove anything. It does tell you that internal checks on aggressive accounting choices are concentrated in one Audit-Committee chair (Mr. Chen Mingyu) and a newly appointed auditor.

Earnings Quality

The income statement is more defensible than the cash-flow statement. Receivables grew far slower than revenue, no reserves were obviously raided, and the auditor's only Key Audit Matter was a standard revenue cut-off review that passed. The earnings-quality concerns are second-order: a meaningful share of operating profit comes from wealth-management gains and government grants, and reserves drift in the helpful direction.

Trade receivables are flat at $67M against $5.3B of revenue — a DSO of 4.6 days that reflects the distributor-prepayment model rather than any accounting choice. The auditor confirmed cut-off testing and distributor existence as part of the FY2025 audit. This is a clean test for the revenue line. What is less clean: contract liabilities (advance from distributors) fell 23% to $45M while revenue grew 31% — distributor confidence in the pipeline did not scale with the print. The shrinkage is consistent with either tighter channel-financing terms or weaker forward orders.

Operating profit of $520M includes $101M of "other income and gains" — 19.5% of operating profit. Of that, $33M is government grants, $25M is VAT super-deduction, and $26M is fair-value gains on $681M of bank-issued wealth-management products and structured deposits. These items are real, recurring under current PRC policy, and disclosed — but stripping them brings operating margin from 9.83% to ~7.9%, and the FY25 print loses ~$83M of "operational" feel. Yadea labels none of these as non-recurring, which is the correct treatment but worth a flag for anyone modelling normalised earnings.

Reserves drift the way a manager who wanted to flatter earnings would want them to drift: receivable allowances and warranty liabilities are released, the rebate accrual builds in line with sales. None of the moves are large enough to swing the headline meaningfully — combined warranty release adds ~$6M to pre-tax profit, less than 1.2% of profit before tax — but the pattern is one-directional.

Cash Flow Quality

This is where the forensic reader should focus. Reported FY2025 CFO is $856M against $41M in FY2024 — a 20× swing. That headline overstates the operational improvement.

CFO/NI = 2.06× in FY2025 and 0.23× in FY2024. The two-year average of 1.50× still sounds healthy, but decomposition shows where it came from:

The single largest contributor is Δ trade and bills payables = +$328M, more than 38% of cash generated from operations. Drilling into the note: trade-payables (the genuine arms-length item) rose only $88M, from $497M to $607M. The other ~$230M of the build is in bills payable, which rose from $1,129M to $1,407M — bank-guaranteed promissory notes secured by $623M of pledged bank deposits. These are functionally a form of short-term bank financing dressed as supplier credit.

A new disclosure in FY2025 makes the picture sharper. Note 29 reveals that Yadea has, in 2025 only, entered into a supplier-finance arrangement: certain suppliers can discount Yadea-issued bills at banks, with Yadea paying the discount interest. Total bills discounted in 2025: $210.9M (FY24: nil). Outstanding at year-end: $154.1M. Settlements stay inside CFO. This is a textbook supplier-finance / reverse-factoring programme — disclosure is in line with HKFRS but the cash-flow classification means working-capital improvements that are actually bank-funded show up as operating strength.

After stripping the bills-payable build and the supplier-finance programme, adjusted CFO is ~$471M and CFO/NI falls to 1.13× — still positive, but the "lifeline" view replaces the "cash-generative compounder" view. FCF after maintenance capex remains positive at ~$355M, so this is not a cash-burning business; it is a business whose headline CFO is amplified by bank-mediated working-capital management.

The FY2024 picture is the inverse and equally instructive. Bills payable fell $241M that year, working capital absorbed cash, and the company's defence at the time was that tax-paid of $58M was the swing item. The honest read is that Yadea's CFO is a working-capital story driven by the bills-payable ledger more than by underlying operations, in both directions.

Metric Hygiene

Yadea's reported headline metrics reconcile directly to the financial statements — there is no adjusted-EBITDA culture and no "cash earnings" framing. The hygiene concerns are subtler.

The two hygiene items that meaningfully change the picture are the gearing ratio (which excludes $1.41B of bank-backed bills payable while including $209M of explicit borrowings) and the net-current-assets narrative. Management explains the FY25 net current liability of $268M as a deliberate decision to reclassify $655M of deposits to non-current to capture higher interest rates. That is plausible treasury management — and it conveniently moves cash off the current-assets line so the working-capital tightness from the bills-payable book is mathematically offset by a non-current asset that the reader has to seek out in Notes 24 and 25.

What to Underwrite Next

Five forensic monitors should sit on the next-quarter checklist.

---

Figures converted from CNY at historical FX rates — see data/company.json.fx_rates. HKD figures (share price, dividends, placement proceeds) converted at the prevailing HKD/USD peg of HK$7.80/US$1.00. Ratios, margins, multiples and share counts are unitless and unchanged.

The People Running Yadea

Governance grade: B. Founder-family control is unusually high (63% via a single Cayman trust), the four independent directors carry genuine professional substance, and capital allocation in 2025 was shareholder-friendly (dividend +141%, no dilutive issuance). But two things pull the grade down: PwC was reappointed at the 17 June 2025 AGM and resigned barely eight weeks later, replaced by Deloitte; and five-highest-paid non-director compensation expanded 6.3× year-on-year on the back of stock awards and bonuses, hinting that the option/award schemes are doing real work for insiders even before they vest.

1. The People Running This Company

Yadea is run by a husband-and-wife founding pair who together control 63% of the equity through a Cayman family trust. Day-to-day operations sit with the four professionals below them, and the board's check on management comes from four independent directors with credible — not ornamental — qualifications.

Dong Jinggui (Chairman, 57) and Qian Jinghong (CEO, 54) founded Jiangsu Yadea together in 1997–2001 after years in motorcycle factories. They are spouses; the company's controlling stake sits in a discretionary family trust they jointly settled. Dong runs the board, Qian runs the business — the separation is real, but the household isn't.

Shen Yu (Executive Director, 51) has been with Yadea since 2005 and acts as joint company secretary. His role is internal — public affairs, chairman's-office liaison — rather than P&L ownership.

Shi Rui (CFO) is a Chinese CPA who joined in 2014; was an executive director from 2014 to 2019 before stepping back to CFO-only. His continuity through three growth cycles is meaningful in a family-controlled company where the CFO is often the first independent check.

The three SVPs — Wang Jiazhong, Zhou Chaoyang, Zhou Chao — are all internal promotions from 1999, 2000 and 2007 respectively. Two have served stints as Group President under a rotating-CEO-of-segment model. This is a thin senior bench: succession on the operating side is not yet diversified beyond the founders.

2. What They Get Paid

Director cash compensation is modest in absolute terms — the Chairman drew $720k and the CEO $544k in FY2025 — but both nearly doubled or tripled year-on-year as the company posted +129% net profit growth and option performance hurdles vested. The real story is the five-highest-paid non-director slot, which jumped 6.3× as stock-award and bonus pools opened.

What the numbers mean. The Chairman's pay went from $357k to $720k and the CEO from $156k to $544k — but that's still well below the median ~$543k the broader market pays CEOs of similar-sized HK-listed peers (Simply Wall St benchmark). At ~$575k of cash compensation between them, the founders are effectively living off dividends on their 63% stake, not off salary.

The Top-5 non-director pool jumped from $1.50m to $9.84m — a 6.3× expansion, driven by $4.03m of share-based compensation (vs $0.31m) and $2.99m of bonuses (vs $0.25m). This matches the vesting math of the 2023 option grant: the third tranche (40%) vested in FY2025 once cumulative revenue and profit growth versus FY2022 cleared the 73% hurdle. Revenue grew 31% in 2025 alone to $5.29bn and profit attributable jumped 129% to $416m — so the targets were beaten, the awards are real, and the dilution exists.

Independent director fees are flat at ~$39k each — at the low end for HKEX mid-caps but consistent with HK norms.

3. Are They Aligned?

Ownership is the answer to almost every question on this tab.

Skin-in-the-game: 8 / 10. Dong and Qian hold 1.96bn shares jointly via the DQ Prosperity Trust (Trident Trust Cayman as trustee). At the late-May 2026 price of $1.45 per share, that stake is worth roughly $2.85bn. Two people. The trust structure means liquidity is constrained (any sale must be disclosed under Part XV SFO; the family has not sold any shares since IPO), and the holding is concentrated in one vehicle rather than split across several lawyers' street accounts.

The score is not a perfect 10 because (a) control is so high it functionally eliminates minority-shareholder veto power, and (b) the executive bench below Dong and Qian holds no disclosed direct stake — alignment exists at the top but doesn't cascade.

Insider activity

There are no director-level open-market sales on record for 2025 — meaningful, given the share price rallied through the period. The company itself was a buyer (~17m shares for the employee award scheme), and the trust held flat. The "Fang Yuan" line reflects a tidy-up of the controlling-shareholder vehicle structure: Fang Yuan transferred out of its 2016 controlling-shareholder declaration in late December 2025 and then returned to the market as a private buyer in March 2026 — read as a re-domiciling of the family's secondary holding vehicle rather than a sentiment signal.

Dilution and option overhang

Capital allocation and related-party behaviour

Capital allocation in 2025 was unambiguously shareholder-friendly: the proposed final dividend of $0.068 per share (+141% versus FY24's $0.028) returns close to $212m to shareholders against the $416m of attributable profit — a payout ratio approaching 50%. The 2022 placement proceeds ($110m raised at a 10% discount) were fully deployed into overseas R&D, manufacturing and distribution by year-end 2025, with the schedule completed on plan.

Related-party transactions: the board reports no Chapter 14A connected transactions for FY2025. Note 39 of the financial statements discloses the routine related-party items (trust-controlled vehicles, employee benefits) that fall below the Chapter 14A threshold. The non-competition undertaking signed at IPO in 2016 (binding Dong, Qian, Dai Wei and Fang Yuan) was certified as complied with by the INEDs for FY2025. No material self-dealing flags emerge from the filings.

4. Board Quality

The board is seven directors: three executive (Dong, Qian, Shen) and four independent non-executives (Wong, Chen, Ma, Liang). That is 57% independent — well above the HKEX one-third minimum. Crucially, the four INEDs are individually substantive, not box-checking.

Where the INEDs add value. Mr. Chen Mingyu (Audit Committee chair) brings exactly the resume the role demands: 35 years across Deloitte, EY and KPMG as a tax/advisory partner, and concurrent INED seats at Sinopharm (Shanghai-listed pharma) and GHY Culture & Media (SGX). Ms. Ma Chenguang (Remuneration chair) is a Chambers Band-1 corporate lawyer in Shanghai with arbitrator credentials and an academic appointment at Fudan. Mr. Wong Lung Ming spent 25 years at Philips, including running Philips DAP Greater China — the closest analogue to Yadea's consumer-durables business inside the boardroom. Ms. Liang Qin is an active electronics-manufacturing entrepreneur (chairwoman of Yangzhou Yangjie Electronic Technology) — adds operating peer perspective.

All four INEDs registered 100% attendance at board, audit and remuneration committee meetings in 2025. INED service contracts run on three-year cycles; Wong's was renewed 29 April 2025 (a third term), the other three INEDs face re-election at the 17 June 2026 AGM.

What the board cannot do. With 63% voting control sitting in the founders' trust, the board's independent element cannot, in practice, force a change of strategy, replace the chairman, or block a related-party transaction the controlling shareholders want. What the INEDs can do — and on the evidence appear to do — is force compliance discipline, vet the audit work, and shape the remuneration policy. Within those bounds, this is a credible board.

5. The Verdict

Upgrade trigger. A clean Deloitte-led FY2026 audit with no opinion modifications, plus continued restraint on new option/award grants relative to the authorised mandates, would move this to B+ / A−. A reduction in family control via a secondary placement (with the proceeds used for buybacks rather than overseas expansion) would close the structural gap that caps the grade today.

Downgrade trigger. Any restatement of FY2024 or FY2025 numbers; disclosure of a dispute that drove the PwC resignation; a top-up of the 2024 Share Option Scheme grants beyond ~3% of issued capital in any single year; or the appearance of a material Chapter 14A connected transaction with a trust-controlled entity.

---

The Story

Figures converted from CNY at historical FX rates — see data/company.json.fx_rates. Ratios, margins, multiples, and percentage growth rates are unitless and unchanged.

The current chapter began in April 2019 when China's revised National Standard for electric bicycles took effect — a regulatory event Yadea repackaged as a tailwind and rode for five years, taking revenue from $1.72bn (2019) to $4.89bn (2023). The chapter nearly closed in 2024, when a Nanjing fire ignited a battery-safety regulatory shock, demand collapsed, revenue fell 18.8% and profit halved — the first miss of the post-listing era. 2025 was a clean comeback (revenue +31.1%, profit +128.8%, sodium-ion battery launched, Vietnam plant opened), validating management's "stay focused on long-term growth" framing through the downturn. Founder-chairman Dong Jinggui has run the company since 2001 and through the entire public-market history, so every promise and pivot tracks back to the same office.

1. The Narrative Arc

Three arcs sit inside this ten-year picture: listing-to-tailwind (2016–2019) when Yadea was a steady mid-teens grower with weak ASP pricing power; tailwind boom (2020–2023) when industry consolidation under the National Standard plus vertical integration into batteries lifted scale and margin together; shock-and-recovery (2024–2025) when regulatory whiplash exposed how much of the prior boom was policy-aided rather than self-generated, and how quickly the same playbook could reignite it. The 2024 break was the first time the founder-chairman had to defend a falling number to the market.

2. What Management Emphasized — and Then Stopped Emphasizing

The most striking pivot: "premium brand / premium pricing strategy" was the lead theme from 2019 through 2023, present in every chairman statement, and disappeared entirely in 2024 — replaced by "reduced selling prices of certain existing models as part of a strategic push to accelerate inventory clearance." Management never acknowledged this as a strategic shift; the phrase simply stopped appearing. The premium framing returned only mutedly in 2025 ("the Company's ability to command a price premium for its products"), but the volume in messaging has been redirected to younger consumers, female riders, sodium-ion technology, and Southeast Asia — a wholesale rebranding executed without ever saying the old positioning failed.

The graphene battery narrative is also notable. Yadea spent four years (2019–2023) calling its TTFAR graphene battery a competitive moat; it has been quietly displaced by sodium-ion since the Nanjing fire made graphene's lead-acid heritage a liability. The graphene generation is not retired in the text — it is simply not mentioned.

3. Risk Evolution

The formal Principal Risks section is remarkably stable — distributors, supplier pricing, IP, international sales, and currency are the five evergreens since 2019. The honest signal lives in the MDA narrative, not the risk inventory. Two new risks were named in 2024: battery-safety regulation (a direct response to the Nanjing fire) and distributor inventory destocking. Both were absent from prior risk discussions despite the latter being a structural feature of the channel model the whole time. Geopolitical risk to overseas operations has crept upward as the Vietnam/Indonesia exposure becomes material, but is still under-discussed relative to the capital allocated there.

What is not in the risk factors that probably should be: trade-credit risk on the trade payables / bills payables stack ($2.01bn at end-2025 vs $0.86bn cash); concentration around the founder family (Dong Jinggui + Qian Jinghong remain joint controlling shareholders); and competitive risk from Niu, Aima, and the Chinese consumer EV migration away from two-wheelers in tier-1 cities.

4. How They Handled Bad News

The 2024 annual report is the most useful document in the file. Yadea explicitly admitted to dropping prices on existing models — not the kind of admission a founder-CEO chairman usually makes about his own brand. Where management was less candid: they never explained why the same regulatory environment that was a tailwind in 2019 became a headwind in 2024. The 2019 New National Standard arrived as a forcing function that consolidated the industry around scale leaders; the 2024 standard arrived as a fire-safety crackdown that destroyed eighteen months of distributor inventory and forced premium-pricing capitulation. Both are regulatory shocks. Only the first was credited as one.

The deeper question — whether the 2019–2023 boom was driven by Yadea's brand and graphene battery, or by industry consolidation handed to them by Beijing — is the one management has not addressed in any document. The 2025 rebound, driven explicitly by the government trade-in program, makes the case that regulation is the dominant variable in this story and the brand is its beneficiary, not the other way around.

5. Guidance Track Record

Credibility = 7/10. Reasoning: Yadea hits its operational targets — acquisitions close on time and integrate, placement proceeds get deployed within the promised window, the 2025 rebound was called accurately one quarter before it materialised. Management was direct about the 2024 miss, naming pricing and destocking explicitly rather than blaming the environment alone. The deduction is for narrative laundering: phrases that no longer fit (premium pricing, graphene battery as a moat) are quietly retired rather than reconciled, and the inconvenient question — how much of the multi-year boom was simply being on the right side of a regulator's standard — is not addressed. A chairman who has run the company for 25 years has unusual leverage to be honest; he uses it inconsistently.

6. What the Story Is Now

The current story is a policy-leveraged scale leader with a working playbook. Yadea has 5,122 dealers, 40,000+ retail points, and the largest installed base in China; the FY2025 rebound proved that when end demand returns, Yadea's distribution and brand convert it to cash faster than any peer. The 2024 stress test answered the more important question: management did not panic, did not gut R&D (held at ~$170m through the trough), did not skip the dividend ($174m paid out for FY2024 including a special), and did not break working-capital discipline — instead executed a discount-clearance cycle and emerged with the sodium-ion product to lead the next regulatory wave.

What has been de-risked:

• Battery vertical integration (Huayu, Huayu Sodium-Electric) is now revenue-positive and central to the regulatory-fit story.
• Overseas manufacturing is no longer a slide-deck promise — Vietnam US$100m smart plant opened early 2026 with 1m-unit capacity; Indonesia underway.
• The placement proceeds promised in 2022 were fully deployed on the announced uses.
• Management proved it can hold a brand together through a 50%+ profit drawdown without strategic reversals.

What still looks stretched or unproven:

• The Southeast Asia revenue base is still single-digit percent of group — the "global leader" framing rests on China-domestic dominance, not international scale.
• The "8 consecutive years top-selling brand" claim, repeated annually, increasingly hides the fact that two-wheeler unit demand has been flat-to-declining in tier-1 China; the volume story has shifted to ASP/mix and overseas, not core domestic.
• Sodium-ion is launched but not yet a meaningful percentage of mix; the technology lead claim awaits financial validation.
• Working capital relies on a $2.01bn bills/payables stack that is structurally larger than cash — fine while volume grows, painful when it contracts.

What the reader should believe: the operational competence, the founder commitment, the capital-return habit, the regulatory positioning post-2024.

What the reader should discount: the premium-pricing-power narrative (broken in 2024); the graphene-battery-as-moat language (quietly retired); the "global leader" emphasis (mostly a China-domestic claim); and any chairman-statement framing that asserts current strategy is identical to a previous one when the metrics show it has pivoted.

---

Figures converted from CNY at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Financials — What the Numbers Say

Yadea earns $5.3B in revenue and $416M in net income (FY2025) selling electric two-wheelers, batteries and chargers — about 18m units a year — at an average gross margin of ~17% across a decade. The story today is a wide gap between accounting quality and market price: the company holds ~$2.5B of net cash (≈58% of market cap), throws off $748M of free cash flow (FY2025), earns 27.8% ROE, and trades at roughly 10× earnings. The FY2024 trough — revenue ‑19%, EPS ‑52% — was a real demand air-pocket as Chinese provinces re-wrote e-bike safety rules, not a structural break. FY2025 reaccelerated on national trade-in stimulus: revenue +31%, operating profit +118%, operating cash flow +1,904%. The single metric that decides the next year is gross margin — whether FY2025's 19.1% recovery holds, or whether it normalises back toward the 15–16% range that preceded it.

Revenue, Margins, and Earnings Power

Yadea's revenue has compounded at ~21% CAGR for nine years but the path is anything but smooth. Three regulatory inflections shaped it: the 2019 GB17761 new national standard (which obsoleted millions of legacy e-bikes and triggered the 2020–2021 scrappage cycle); the 2024 GB17761 revision (which paused dealer ordering and crushed FY2024); and the 2024–2025 national trade-in subsidy programme (which pulled demand back in FY2025). The earnings power therefore looks much steadier when you read it as a cycle: trough operating margin ~6%, mid-cycle 8–9%, peak ~10%.

The decade splits into three regimes. 2016–2019 was the dealer-network land-grab phase: revenue grew 20–26% a year but margins compressed because Yadea was buying volume from competitors. 2020–2023 was the GB17761 super-cycle: the national rule forced replacement of ~300m sub-standard scooters, revenue tripled, and net income compounded 5× as Yadea took share and lifted gross margin to 18.1% in 2022. 2024–2025 is the new cycle: the revised rule briefly broke demand, then the trade-in scheme catalysed an even larger replacement wave that is still running.

The FY2025 gross-margin print (19.1%) is the highest in the dataset and was driven by three combinable factors: (i) lithium-iron-phosphate battery cost deflation passed only partly to customers, (ii) more premium model mix as the trade-in scheme pulled customers up-tier, and (iii) better factory utilisation as volume rebounded to ~18m units. None of these are durable on their own. The realistic mid-cycle gross margin is 16–17%, and the FY2025 print should be read as the high end of a band, not a new floor.

The half-year view exposes the cyclical engine: H2 2024 was the demand vacuum (NI $33M, ‑77% YoY), H1 2025 was the trade-in bounce (NI $230M, +60% YoY), and H2 2025 stayed strong (NI $180M, +430% YoY off the low base) but was sequentially below H1 — a normal seasonal pattern as scooter sales weight toward spring.

Cash Flow and Earnings Quality

Yadea's recent cash flow tells a much louder story than its income statement. Cash from operations swung from $41M in FY2024 (0.23× net income — a red flag) to $856M in FY2025 (2.06× net income — exceptional). The swing is not accounting magic; it's the natural rhythm of a working-capital-heavy distribution business in a downturn-then-bounce.

Two observations matter most. First, the 2,000% YoY jump in operating cash flow is not a normal earnings recovery — it is dealers refilling channel inventory after running it dry through FY2024. Some of FY2025's OCF therefore "belongs" to FY2024 (the working-capital release that should have happened then). A normalised FY2025 OCF would be lower — probably in the $500–570M range — but still very healthy. Second, capex halved in FY2025 (from $206M to $112M) as Yadea finished its overseas factory build-out. With factory capacity now in place, capex intensity should run at ~2% of revenue, freeing more cash for shareholders.

Balance Sheet and Financial Resilience

The balance sheet is the most important slide in the deck. Yadea operates with near-zero interest-bearing leverage but very high trade-payable leverage — a structural feature of consumer-goods OEMs with bargaining power over suppliers. The right way to read it is to separate financial debt from operating liabilities.

Yadea sits on $2.7B of cash and cash-equivalents versus $0.23B of financial debt — net cash of $2.5B. That is 47% of FY2025 revenue and 58% of the company's market capitalisation. Read literally: investors are paying $4.2B for an operating business that has $2.5B sitting inside it, so the operating enterprise is being valued at roughly $1.8B EV against $520M of operating profit — barely 3.4× operating profit.

The reported "debt-to-equity" of 1.87× looks ugly but is misleading: it includes $2.0B of trade and bills payable to suppliers — short-term, non-interest-bearing, and a sign of strength not weakness. The real signal is the equity ratio (equity / total assets) climbing from 22% in 2020 to 35% in 2025 — the company has been recapitalising itself by retaining earnings while suppliers continue to fund working capital. Interest expense was just $6.6M in FY2025 against $520M of operating profit — interest coverage is meaningless because there is barely any interest.

Returns, Reinvestment, and Capital Allocation

Returns are the cleanest evidence that this is a quality franchise, not a commodity OEM. ROE has averaged 23% over six years and hit 27.8% in FY2025. The variability tracks the operating cycle, not the business model.

The capital allocation story is consistent and gets stronger with cash generation: Yadea pays a real, growing dividend and buys back small amounts opportunistically. There is no empire-building, no transformational M&A, and no dilution.

The FY2025 dividend ($179M) is 45% greater than the FY2024 dividend, the buyback was smaller ($7M vs $18M), and no acquisitions were made versus a $25M deal in FY2024. Share count is effectively flat at ~3,040M (the buybacks roughly offset RSU vesting). At the current price, the dividend yield is approximately 4.2% and the implied FCF yield ($748M FCF / $4.23B market cap) is 17.6% — far above any plausible cost of equity for a Hong Kong consumer-goods name.

Segment and Unit Economics

Yadea reports a single operating segment under IFRS 8 but discloses a useful product mix breakdown. The mix has been remarkably stable across the cycle, which tells you the demand swings hit every product line at once — i.e., it's a category phenomenon (regulation, trade-ins), not a product-line phenomenon.

Electric scooters are now 44% of revenue and growing the fastest in absolute terms. The batteries and chargers line is the under-appreciated profit pool — it has a higher attach rate than vehicles (every new vehicle needs a battery; replacement batteries every 2–3 years generate recurring revenue), and Yadea has been vertically integrating sodium-ion battery production. As geographic mix moves more international (factories now in Vietnam, Indonesia, and others), product mix should tilt toward higher-ASP electric scooters with better gross margin.

Valuation and Market Expectations

This is the most important section of the page. The current share price prices Yadea at a level normally reserved for stressed, no-growth manufacturers — yet the underlying business has grown revenue 21% per year for a decade, holds 58% of its market cap in cash, and just delivered 28% ROE.

The 10-year history shows three valuation regimes: pre-2019 (low-teens P/E for a 5% net margin commodity OEM), 2020–2021 (peak ~40× as the GB17761 super-cycle convinced markets Yadea was a growth compounder), and 2022 onwards (steady de-rating to ~10–15×). FY2025's print sits at the bottom of that range — only the 2016 IPO year was cheaper on P/E.

The right multiple for Yadea is EV/EBITDA, not P/E, because the cash hoard distorts every equity multiple. EV/EBITDA of ~2.8× is a low multiple for a global #1 by units. A re-rating to 6× — still below the China consumer-goods average — would imply an enterprise value of $3.7B, plus $2.5B of net cash, ≈ $6.2B equity, or roughly 45% above the current $4.2B market cap. Sell-side consensus (mean target HK$15.15) sits ~36% above HK$11.27 — the framing agrees.

The bear scenario still sits ~14% above HK$11.27 because the net cash floor is so high. The base scenario (HK$14.28) lines up with the sell-side mean (HK$15.15). The bull scenario requires the FY2025 gross-margin print to hold and a partial re-rating toward Chinese consumer-discretionary norms — neither extreme.

Peer Financial Comparison

The peer set is the single most damning piece of evidence that the market is mispricing Yadea. Across the three China-listed peers and the two international comps, Yadea ranks #1 on scale, #1 on returns, and yet trades at the lowest EV/EBITDA of any peer that earns positive EBITDA.

The peer gap that matters: Yadea trades at 2.8× EV/EBITDA against AIMA's 7.8× and Ninebot's 12.7×. The simplest defensible explanation is that AIMA's FY2024 net income ($292M) was higher than Yadea's ($174M) and the market over-extrapolated the cyclical inversion. That earnings gap reversed in H1 2025 (Yadea NI +60% YoY, AIMA NI +28% YoY) but the multiple has not. A peer-average EV/EBITDA of ~8× would imply an equity value of $7.4B against the current $4.2B — roughly 74% above today's mark. That is the size of the gap.

What to Watch in the Financials

The financials confirm four things: (i) Yadea is the highest-quality operator in Chinese e-mobility by margin, return, and balance sheet; (ii) the FY2024 trough was real but cyclical, not structural; (iii) the company throws off enormous free cash flow when working capital normalises; (iv) management returns cash through dividends but is too conservative on buybacks given the multiple.

They contradict the bearish read that Yadea is a low-quality commodity OEM losing share. Net income grew 129% in FY2025 and operating margin nearly doubled — that is not a melting ice cube.

The first financial metric to watch is gross margin in the H1 2026 interim. If it holds above 17%, the FY2025 re-rating case stays intact; if it falls back to 15–16%, the bear case (cyclical peak, structural margin pressure from raw-material reversion) gets the evidence. Everything else — cash, returns, dividends, peer multiples — already tilts long; gross margin direction is the swing variable for the next 12 months.

---

Web Research — Yadea Group Holdings (1585.HK)

Figures converted from CNY at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged. HKD figures (analyst price targets, dividends, share price, ISS scores) are quoted in HKD by the underlying sources and presented here with USD equivalents where useful.

The Bottom Line from the Web

The web reveals two facts the filings alone do not foreground. First, Yadea has had two Big Four auditor exits in five years — Deloitte resigned in July 2020 over an audit-fee dispute, PwC was reappointed at the June 2025 AGM and then resigned 56 days later, with Deloitte re-engaged in September 2025 — a pattern that should be the first item on any forensic checklist. Second, the spectacular 2025 rebound (revenue +31% to $5.29B, net profit guided to ≥$414M from $174M in 2024) is heavily levered to the China NDRC trade-in subsidy, which has been extended for 2026 but with structural changes that may compress the boost. Everything else — Vietnam capacity, sodium-ion launches, Xiaomi-backed Ninebot's share gains — sits downstream of those two questions.

What Matters Most

1. Two Big Four auditor exits in five years — PwC quit 56 days after reappointment

Sources: MarketScreener — Yadea: CHANGE OF AUDITOR (2020); Tiger Brokers — Yadea Group Appoints Deloitte as New Auditor Following PwC Resignation, 22-Sep-2025.

2. 2025 earnings doubled — but the trade-in subsidy did most of the work

Sources: Simply Wall St via Tiger Brokers — "Why Yadea Is Up 6.2% After Issuing Strong 2025 Profit Guidance," 09-Jan-2026; 36kr — "Two-Wheeler Market Booms: Why Did Yadea and Aima Fall Behind Ninebot?"; Metal.com — NDRC/MoF 2026 trade-in policy notice, 30-Dec-2025.

3. Ninebot (Xiaomi-backed) is gaining share — Yadea is now defending, not extending

Sources: 36kr H1 2025 industry recap; Yicai Global — "Yadea and Emma's performance was weak, Nine's profits soared," 18-Apr-2025.

4. 2024 was worse than the industry — Yadea's volume decline was nearly 2x the market

The Yicai Global summary of the 2024 annual reports: Yadea's total unit sales fell 21.18% to 13.02M (electric bicycles -21.4% to 9.09M; electric scooters -20.7% to 3.93M) while the broader China electric two-wheeler market fell only 11.6%. Inventory grew +33.9% to $175M. Revenue dropped from $4.89B (2023) to $3.87B (2024), a decline of 18.7%; net profit fell 52%. The 2024 underperformance preceded the 2025 rebound and shaped management's pivot toward overseas, premium, and lifestyle-targeted product launches.

Sources: Yicai Global, 18-Apr-2025; InsightEV — "Yadea and the New Chinese"; MotorCyclesData — Yadea Global Sales 2025 +26.5%.

5. Vietnam Bac Ninh smart factory opened 01-Mar-2026 — 1M-unit phase-1 capacity

Sources: Vietnam News — "YADEA inaugurates $100 million smart factory in Bac Ninh," 02-Mar-2026; OurMechanicalWorld, 09-Mar-2026; MotorCyclesData — 10 manufacturing facilities outside China by end-2025.

6. Family control is extreme — and ISS governance score is in the worst decile

Sources: Yahoo Finance — Yadea Profile & Governance, ISS QualityScore (May 2026); MarketScreener — Shareholders, Shareholding Structure; Yahoo Finance — Insider Roster (YADGF); Investing.com Ownership; Forbes — Qian Jinghong billionaire profile.

7. Valuation looks cheap on every external screen — analysts agree

Sources: ValueInvesting.io — Relative Valuation P/E; ValueInvesting.io — DCF Growth-Exit 5Y; Morningstar — 01585 Quote; Stock Analysis — HKG:1585; MarketScreener — Consensus.

8. Dividend cut in 2024, restored in 2025 — payout policy is now consistent ~43-50%

FY2024 ordinary dividend was reduced (Simply Wall St headlines flagged the cut). FY2025 final dividend is $0.068 per share (ex-date 23-Jun-2026, payable 16-Jul-2026), plus a special $0.029 paid in 2025. Trailing yield ~4.7%, payout ratio ~43-50%. The 63% family stake means dividend policy is set by the controlling shareholders' preference, not minority-shareholder pressure. The special dividend is the meaningful new signal — it lifts the cash-return floor materially.

Sources: Stock Analysis — Dividend History; Simply Wall St — Yadea Dividends & Buybacks; CBonds — 25-Mar-2025 "Yadea Reports 52% Lower 2024 Profit".

9. Sodium-ion battery launch is real, but volumes are opaque

Sources: InsightEV — "Yadea brings Sodium Ion to the market," 13-Jan-2025; The Pack News, 10-Jan-2025; MarketScreener press release, 08-Jan-2025.

10. No short-seller, SEC, SFC, or HKEX enforcement action surfaced

Specialist queries searched explicitly for short-seller reports, SFC/HKEX enforcement, controversies, and class actions. Nothing material returned. The forensic specialist's "find external forensic allegations" query returned only generic press and Wikipedia. This is a clean negative — but the absence of external forensic noise should be weighed against the audit-rotation pattern (#1) and the worst-decile ISS scores (#6).

Sources: SustainAlytics — Yadea ESG profile (no controversy flag in the public snippet); Wikipedia — Yadea; forensic-research.json queries returned no matching enforcement records.

Recent News Timeline

Key Metrics from the Web

What the Specialists Asked

Governance and People Signals

The governance read combines a tight family-control structure, a structurally weak external rating, and a recurring audit-rotation pattern. Each is fact-based; the combination is what should drive the read.

Key People

Source: Yahoo Finance — YADGF Company Profile (Executives + governance); MarketScreener — Yadea Shareholders.

Ownership Structure (per external sources)

Note: MarketScreener and Investing.com show overlapping but not identical institutional rosters; the table aggregates both. Trident Trust Company (Cayman) holds 64.49% as nominee, which captures the Dong+Qian block (62.96%) plus other Cayman vehicles. Float-equivalent shares ~1.08B of 3.04B total.

Audit-Rotation Timeline

Industry Context

The China electric two-wheeler industry is consolidating in the wake of the 2024 lithium-battery regulation overhaul and the NDRC trade-in program. The structural picture from the web research:

Cycle. 2021 was the peak unit-sales year (Yadea hit 6M units). 2022-2024 was a three-year volume contraction driven by (a) major-city two-wheeler restrictions, (b) replacement of two-wheelers by metro + private cars, (c) post-pandemic destocking, and (d) the late-2024 lithium battery rules forcing model redesigns. 2025 is the rebound year (H1 industry sales +29.5%, Yadea global e-scooter +26.5%), pulled forward partly by the trade-in subsidy.

Structure. Mordor Intelligence classifies the global electric two-wheeler drivetrain market at US$81.4B (2025) → US$129.4B (2030), 9.7% CAGR, with Asia-Pacific dominant and concentration "Medium." Yadea is the global #1 by units (4.8M e-scooters in 2025) but 95% of revenue is still mainland China — a structural ceiling that the overseas-plant build-out is intended to lift.

Competition. Marketsandmarkets identifies VinFast, TVS Motor, Bajaj Auto, Ather Energy, and Ola Electric as the top-5 holding 40-50% in India's E2W market — implying Yadea's India opportunity is limited unless local-production or partnership entry happens. In China, the top-5 hold over 50% per industry research, with Yadea (26.3% H1 2025), AIMA (~12-15%), Luyuan, Ninebot (rising fast), and Tailing forming the core. The Reuters thesis on China autos — "169 brands fighting it out, only 14 above 2% market share" — applies more to four-wheelers, but the directional message (cutthroat price competition, margin pressure) reads across.

Technology shifts. Sodium-ion battery commercialization (Yadea January 2025, expected industry follow-on) is the most significant new chemistry trend; advanced/smart connected scooters are the premium-mix lever (Yadea Crown i7 / Starship II / White Shark II 2026 flagship lineup starting at $725); 10kW+ electric light motorcycles (Yadea Keenness VFD) push toward higher-margin sub-segments. The Porsche Design partnership (VF F200 e-scooter, 2023) and the Modern series targeting female riders (H1 2025) signal a shift away from commodity e-bikes.

Regulation. The NDRC + MoF 2026 trade-in policy notice (30-Dec-2025) extended consumer-goods subsidies into 2026 with restructured terms. China's strict lithium-battery and Standard Conditions rules continue to consolidate share away from the long tail of ~80 small OEMs. SAMR / MIIT enforcement is intensifying — no Yadea-specific actions surfaced.

Sources: Mordor Intelligence; Marketsandmarkets; Reuters — China's cutthroat EV revolution; InsightEV — Yadea and the New Chinese; BigGo News — 2026 flagship launch; NDRC/MoF 2026 trade-in notice via Metal.com.

---

Figures converted from CNY at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Web Watch in One Page

The Yadea long-term case turns on five observable things outside the next quarterly print: whether the Dong/Qian family converts the $2.47B cash pile into a sustained capital-return regime, whether governance and the new Deloitte audit relationship hold through FY2026, whether the H1 2026 interim resolves the bills-payable and supplier-finance questions the forensic page flagged, whether Beijing's Standard Conditions and the 2026 NDRC trade-in implementation rules actually consolidate the long tail, and whether AIMA and Ninebot allow Yadea's scale-and-integration thesis to convert into a sustained operating-margin gap. The five active monitors below each track one of those questions and flag only material changes — a dividend declaration, a buyback authorization, an auditor or INED change, a new HKEX cash-flow disclosure, a regulator notice, or a peer-print step-change. Routine news and re-publishings of already-priced facts are filtered out.

Active Monitors

Rank	Watch item	Cadence	Why it matters	What would be detected
1	Yadea capital-return cadence — dividends, specials, buybacks, payout-floor language	Daily	The single multi-year signal that can re-rate the operating business toward AIMA's 7.8× EV/EBITDA; closes or confirms the $2.47B stranded-cash discount	Any HKEX disclosure of an interim or special dividend, a structural buyback authorization, AGM resolutions on share-issuance/buyback mandates, or chairman-statement language committing to a payout-ratio floor
2	Auditor and board governance integrity — Deloitte relationship, INED composition, restatements	Daily	A third Big-Four resignation, an expanded Key Audit Matter, an unexplained INED departure, or a Cayman trust restructuring would crystallize the worst-decile ISS QualityScore as the correct read and lock in the cash discount	Deloitte change-of-auditor or modified-opinion filings, audit-committee chair succession news, INED resignations, restatement notices, or trust-vehicle / controlling-shareholder transfer disclosures
3	H1 2026 interim results — bills payable, supplier finance, CFO/NI	Daily	The forensic test of whether FY2025's $0.86B reported CFO was real or bank-mediated; bills payable >$1.57B or supplier-finance outstanding >$0.29B would invalidate the variant thesis	Late-August 2026 board-meeting notice and interim results announcement; balance-sheet bills-payable line; Note 29 supplier-finance disclosure; interim dividend declaration; any review-note language from Deloitte
4	China electric two-wheeler regulatory cycle — NDRC trade-in curve, MIIT Standard Conditions, lithium safety rules	Weekly	Driver #1 of the long-term thesis. The 2026 NDRC two-wheeler subsidy curve, MIIT enforcement cadence on Standard Conditions, and provincial roll-outs determine whether top-5 share moves from ~50% toward 60%+	New NDRC/MoF/MIIT notices on the 2026 two-wheeler trade-in curve, Standard Conditions enforcement actions or registration-count updates, lithium-pack certification changes, and provincial implementation circulars
5	AIMA and Ninebot — operating-margin gap and E2W unit trajectory	Weekly	Durability test #1 (scale + integration = better economics) and failure mode #5 (premium-tech entrant). AIMA matching or beating Yadea on operating margin in FY2026 falsifies the moat-on-profitability thesis	AIMA (603529.SS) and Ninebot (689009.SS) interim/annual filings, segment disclosures on E2W units and ASP, profit alerts, and any framing of Yadea as the share-loss target in trade press

Why These Five

The report's verdict — Lean Long, Wait For Confirmation — rests on two unresolved underwriting questions. The first is whether the controlling family converts the $2.47B cash pile into sustained capital returns; that decision unfolds across the 17-Jun-2026 AGM, the H1 2026 interim dividend declaration, and the FY2026 final dividend in March 2027, which is why Monitor #1 has to run live every day a Yadea HKEX announcement could land. The second is whether the FY2025 cash-flow print survives the H1 2026 audit-review scrub without further bills-payable build, which is Monitor #3. Between the two sits the governance ceiling on the entire thesis — the PwC-to-Deloitte swap, the Wong Lung Ming INED departure, and the worst-decile ISS QualityScore mean that any further auditor or board event is a thesis-breaker; that is Monitor #2. The two outer-loop monitors are the slower drivers that determine the multi-year operating-business multiple: Monitor #4 captures the regulatory consolidation tailwind that the moat math depends on, and Monitor #5 tests whether scale-and-integration actually converts into a sustained operating-margin lead over the only profitable scale peer. The set deliberately excludes generic "latest news" sweeps and the SFC short-position weekly print — both are already in the report and neither would change the 5-to-10-year underwriting case on its own.

---

Figures converted from CNY at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Where We Disagree With the Market

Our sharpest disagreement: the market is pricing Yadea's $2.47B cash pile as permanently stranded and the FY2025 19.1% gross margin as a subsidy-driven peak — together producing a 10.2× headline P/E and a 2.8× operating EV/EBITDA. The report's evidence says the cash discount is already inflecting (FY25 payout +245% YoY with a special, capex collapsed to 2% of revenue, no acquisition runway) and the gross-margin reset is being misread because the post-Nanjing lithium rule is a regulatory ratchet that holds the BoM floor at sub-scale OEMs, not at Yadea or AIMA. The market believes Yadea is a cyclical commodity OEM whose FY2025 print was policy-aided and whose family controllers will not surface the cash; both legs of that belief are testable. The single observable that would resolve the debate over the underwriting horizon is the FY2026-27 capital-return cadence — a second special dividend, a structural buyback authorization of at least $143M, or a stated payout floor would compress the discount toward AIMA's 7.8× EV/EBITDA. If instead the FY26 final dividend reverts to US$0.068 with no special and buybacks stay nominal, the bear's "permanent yield-trap" call is correct and our variant view dies.

Variant Perception Scorecard

A 62/100 variant-strength reflects an edge that is real but not extreme: the operating-business multiple gap to AIMA is unambiguous, the FY25 capital-return inflection is observable, and the regulatory-ratchet thesis on gross margin is grounded in the post-Nanjing lithium rule plus the 2024-25 MIIT Standard Conditions. The 72/100 consensus-clarity score reflects a tape that is doing the work for us — US$1.44 at the 14th percentile of the 52-week range, a fresh death cross on 13-Nov-2025, and SFC reportable shorts that rebuilt +25.7% over seven months tell us where the market sits even though only two sell-side brokers publish. The 65/100 evidence-strength score reflects that the forensic page legitimately flags cash-flow-quality questions and the governance overhang is real; the variant view is calibrated, not maximalist. Resolution is multi-print — 12 to 24 months — because no single H1 2026 disclosure proves capital-return regime change.

Consensus Map

The five-issue map is bifurcated. On issues #1 (cash discount) and #4 (CFO quality), the tape consensus is harder to read than the published-broker consensus because Jefferies (PT US$2.30) and the analyst-screen aggregators (StockAnalysis Strong Buy, PT US$2.23) imply +55% upside that the tape ignores. Where the tape and broker consensus agree — issues #2 (margin reversion) and #3 (Ninebot share threat) — the variant view has the cleanest disagreement.

The Disagreement Ledger

Disagreement #1 — the cash discount. Consensus reads the operating business as a fair-multiple cyclical OEM and prices the $2.47B cash pile as if a 63% Cayman trust will never let it out. Our evidence is that the family has already moved at the margin — capex collapsed from $214M to $108M, ROE printed 27.8% with no incremental reinvestment runway in China, and the FY25 declared distributions of US$0.097 are +245% versus FY24's US$0.028. If the variant view is right, the market has to concede that AIMA's 7.8× EV/EBITDA is the right anchor for Yadea's operating business and that the cash gets distributed rather than discounted; the cleanest disconfirming signal would be a flat US$0.068 FY26 final dividend with no special and a buyback authorisation under $14M.

Disagreement #2 — the gross-margin regulatory ratchet. Consensus prices the FY25 19.1% gross margin as a subsidy-driven peak that reverts to FY24's 15.2% or the FY22-23 average of ~17%. Our evidence is that the post-Nanjing lithium rule and the 2024-25 MIIT Standard Conditions impose a fixed-cost minimum (R&D >=2% of sales, tooling >=$143k, mandatory pack certification) that mathematically removes the sub-scale OEMs whose discount pricing has historically capped Yadea's GM. If the variant view is right, the market must concede that mid-cycle GM lifts to 16-18% and normalised earnings to ~$286M (not the bear's $200M anchor). The cleanest disconfirming signal would be an H1 2026 GM below 17% with AIMA matching at the same level — both confirming that price competition didn't actually withdraw with the long tail.

Disagreement #3 — the Ninebot defender narrative. Consensus, anchored by the 36kr and Yicai post-H1 2025 framing, reads Yadea's "performance adjustment" against Ninebot's +102% E2W revenue growth as share loss to a Xiaomi-ecosystem rival. Our evidence is that Yadea FY25 units grew +25% to 16.3M (above the FY23 peak), Ninebot's H1 2025 E2W base of 2.39M is ~9% share versus Yadea's ~26%, and the H1 2025 China industry grew +29.5% — both companies are riding the same regulatory consolidation wave from opposite ends of the price spectrum. If the variant view is right, the multiple gap between Ninebot (21.3× P/E) and Yadea (10.2× P/E) overstates the threat to Yadea's mass-market position. The cleanest disconfirming signal would be Ninebot E2W units approaching Yadea's pace in H1 2026 (>=40% growth on an already-large base) combined with a Yadea ASP stall or decline.

Disagreement #4 — the horizon mismatch. Consensus and our own catalysts page concentrate decision weight on the August 2026 H1 interim print as the single resolving event for cash-flow quality, gross margin, and capital-return cadence. Our evidence — drawn from the long-term thesis page — is that the durable underwriting variable (capital-return regime) resolves over three signal events: the 17-Jun-2026 AGM mandate vote, the H1 2026 interim dividend declaration (Aug 2026), and the FY26 final dividend declaration (Mar 2027). If the variant view is right, a PM who waits for August 2026 alone is buying optionality on a multi-print sequence; the August print partially answers the question but cannot fully resolve it. The cleanest disconfirming signal would be a clean H1 2026 print where bills-payable contracts, GM holds at 19%+, and the family declares no interim special — proving that one print does in fact resolve both the cash-quality and the regime-change questions in a single document.

Evidence That Changes the Odds

How This Gets Resolved

The eight signals cluster into two windows. Signals #1, #4, and #5 resolve within 90 days and stress-test the H1 26 cash-flow quality question that the bears prioritise. Signals #2, #3, #6, and #7 resolve over 12-24 months and stress-test the durable capital-return and competitive variables that the variant view actually depends on. Signal #8 (SFC SPR direction) is the implementation-side tell — it does not update the thesis but it telegraphs whether the institutional book is reading the same evidence the way we do.

What Would Make Us Wrong

The cleanest refutation of the variant view is governance, not operations. A third Big-Four auditor exit, an expanded Deloitte Key Audit Matter on revenue cut-off or payables classification, or a Cayman trust restructuring that telegraphs a partial-sale path would crystallise the worst-decile ISS QualityScore as the correct read on this name. The structural argument — that the family will surface the cash because there is no reinvestment runway — depends on the family choosing the path that makes economic sense. If governance fails, the family is revealed to have chosen optionality over economics, and the cash discount becomes permanent regardless of capex intensity, ROE, or capital-allocation math. The forensic page's elevated 48/100 risk score is the institutional-grade flag for this scenario; we should not pretend it doesn't exist.

The second-cleanest refutation is competitive. The Ninebot share-loss narrative looks weak from H1 2025 data alone, but the test runs for several more years. If Ninebot's E2W units exceed 4M in H1 2026 (growth holding at 60%+) and Yadea's ASP stalls or contracts, the trade-press framing was correct and the moat is narrowing at the premium end. The variant disagreement on this would die. Equally, if AIMA prints H1 2026 operating margin at or above Yadea — repeating the FY24 outperformance pattern in a non-trough year — then Yadea's claimed "scale + integration = better economics" thesis is empirically falsified and the AIMA-discount peer-rerate math collapses. Both of these are observable in 12 months.

The third refutation is the one the forensic and short-interest pages already point to. If H1 2026 shows bills payable expanding past $1.57B with the supplier-finance book growing past $286M, and CFO ex-Δ-bills tracks below 0.8× of NI, then the institutional short positioning is correct that FY25 CFO was bank-mediated and the durable FCF base is materially below what the variant view requires. The bull case for cash return depends on a sustainable $570-714M mid-cycle FCF; if the FY25 print was working-capital release plus subsidy-peak earnings plus supplier-finance window-dressing all stacked, then the FY26 trough hits before the FY27 recovery and the family delays cash return as a defensive measure. This scenario is internally consistent with everything the bears have written; the report's lean-long verdict assumes it doesn't happen.

The fourth and quietest refutation is what we get wrong if all three of the above are mild: the published consensus (Jefferies Buy US$2.30, ValueInvesting screens US$2.94-3.70, StockAnalysis Strong Buy US$2.23) could already be correct, the tape is wrong, and the variant view is just a slower version of consensus. In that scenario the August 2026 print prints clean, the family does declare a second special, and the H1 2027 stock prints US$1.92-2.17 mechanically — but the variant view added no edge because the consensus call was right all along. The honest read of this risk is that disagreement #4 (horizon mismatch) is partly a hedge for the case where the consensus is right; if it is, the right action is to sell into the print rather than wait for FY26 final.

The first thing to watch is the 17-Jun-2026 AGM resolutions for any buyback authorisation language and any chairman-statement payout-floor commitment — that is the single highest-leverage signal in the next 18 days and the one that most cleanly distinguishes the variant view from the bear's permanent yield-trap call.

---

Figures converted from HKD at historical FX rates — see data/company.json.fx_rates. The HKD–USD currency peg means converted price levels track 1:1 with the native series. Ratios, margins, percentages, and technical indicators (RSI, MACD, realized vol, momentum scores) are unitless and unchanged.

Liquidity & Technical

Yadea trades around US$9.5M per day at 20-day ADV, enough to support a 5% portfolio weight for funds up to roughly US$180M in AUM — institutionally usable but small-cap by Western standards, with the bigger constraint sitting in the tape rather than the throughput. The tape itself is bearish on a 3–6 month view: price sits 8.6% below the 200-day, the most recent 50/200 cross was a death cross on 13-Nov-2025, and the stock is pinned in the bottom 14% of its 52-week range with sponsorship fading rather than capitulating.

1. Portfolio implementation verdict

2. Price snapshot

The 5-year return through the post-2020 bubble (peak US$3.06 in early-2021) and back down captures the boom-and-bust regime more honestly than beta. Today's US$1.44 is roughly half the all-time high and within touch of the 2024 low.

3. Critical chart — full-history price vs 50/200 SMA

Price is below the 200-day SMA by 8.6% (current SMA200 ≈ US$1.57, SMA50 ≈ US$1.55). This is a downtrend regime, not a sideways one. The 50-day has now slipped under the 200-day for the third time in 2025.

The chart resolves three distinct regimes: the 2016–2019 base around US$0.25, the 2020–2021 e-bike bubble peak at US$3.06, and the 2022–2026 secular grind down to today's US$1.44 — closer to the 2019 highs than to the 2021 peak.

4. Relative strength vs benchmark

No broad-market benchmark series is available in the dataset for the HKEX-listed share class (the upstream feed returned an empty benchmark set), so the chart shows Yadea's own rebased price journey from t=−756 trading days (≈3 years). At base = 100 in April 2023, the stock now trades at 61.5 — a cumulative 38.5% drawdown over the period when the Hang Seng Index drifted sideways and global EV-adjacent equities recovered.

The series tracks a slow-burn de-rating, not a single shock: two distinct downlegs (Aug-2023 and Jun-2024) and a March-2025 attempted rally that failed near 85. Each subsequent rally peak has been lower — classic lower-highs signature of a name being distributed rather than accumulated.

5. Momentum panel — RSI and MACD histogram

RSI sits at 34.7 — not technically oversold (sub-30) but in the bottom third of its range, and trending lower since the October 2025 peak near 68. The MACD histogram has been negative in 12 of the last 18 weekly observations and the latest reading (−0.065) is below the signal line and still falling, confirming downward momentum on the daily timeframe.

The composite read: short-term momentum is bearish but not panic-driven. RSI in the mid-30s combined with negative MACD says "tired downtrend" rather than "crash." A counter-trend bounce could materialize from these levels, but without a positive momentum divergence (RSI rising while price stays flat or falls further), there is no high-confidence setup for a long entry yet.

6. Volume, volatility, and sponsorship

Two facts to anchor: the 60-day ADV is higher than the 20-day ADV (US$14.7M vs US$9.5M), meaning sponsorship has been thinning over the most recent month rather than expanding, and median daily range has been a relatively wide 2.97% — material for any institution sizing meaningfully.

The single notable spike inside the last 12 months — 23-Mar-2026 at 8.06x the 50-day average on a +10% close — was a counter-trend rally on no announced fundamental catalyst that the broader market promptly faded. That is not the signature of accumulation; it is short-covering or programmatic positioning that did not produce follow-through.

Realized vol of 24.5% sits below the 5-year 20th-percentile band (27.2%) — a "calm" reading. Reading the two together: price is grinding lower with shrinking dispersion and shrinking volume. That is the orderly-distribution signature — patient unwinding from larger holders, not panic. It also means the demanded risk premium has not yet expanded, so the easier asymmetric trade is to wait for either (i) a vol spike on a clean break of US$1.36 (sponsorship-flush), or (ii) a vol expansion on a reclaim of the 200d (regime change).

7. Institutional liquidity panel

A. ADV and turnover

The 60-day ADV running 55% above the 20-day is a sponsorship signal worth noting on its own: recent activity is below trend, consistent with the death-cross volume profile and the falling volume bars chart above. Median daily range of 2.97% is elevated — anything above 2% means meaningful intraday cost for size, and Yadea trades like a small-cap on this metric despite its global #1 e-bike position by units.

B. Fund-capacity table — supported AUM by position weight

Read the rightmost columns: at a conservative 10% ADV participation, a 5% position weight is implementable for funds up to US$90M AUM. At 20% participation — aggressive but common for high-conviction names — that doubles to US$180M. A 2% bench position works for funds up to roughly US$450M. For dedicated mid-cap China or HKEX small-cap funds these numbers are workable; for larger flagship funds, this would be a small line that doesn't move the portfolio.

C. Liquidation runway

Days-to-exit at fixed % of market cap cannot be calculated without a confirmed share count, but the inverse view — how many days a given US$ position value takes to clear — can be done directly from ADV.

D. Price-range proxy

Median 60-day daily range of 2.97% is above the 2.0% threshold I treat as "elevated impact cost." Combined with the small-cap throughput, this argues for VWAP-style execution over multiple sessions for any position above US$6M and a hard cap of 20% participation; a market-on-open or IS strategy will leak alpha here.

Bottom line: the largest position that clears the five-day window at 20% ADV participation is roughly US$9M, half that (~US$4.5M) at a more conservative 10% participation rate. Beyond that size, expect a multi-week build-and-exit cycle with visible tape impact.

8. Technical scorecard and stance

Stance — 3 to 6 month horizon: bearish. Five of six dimensions score negative and the only neutral reading (volatility) reinforces the bearish thesis rather than offsetting it: a calm, low-vol downtrend in a small-cap consumer-cyclical name almost always reflects measured institutional distribution, not exhaustion. The fundamentals tab's concerns about margin pressure and rising e-bike competition map cleanly onto the price action — the two narratives agree, and there is no constructive divergence to lean on.

Two levels that change the view:

• Bullish trigger: clean reclaim of the 200-day SMA at US$1.57 on expanding volume (above the 50-day ADV). That would invalidate the November death cross, push RSI back through 50, and likely flip MACD positive. Until then, every bounce should be treated as a sell-the-rip opportunity for existing holders.
• Bearish confirmation: break below the 52-week low at US$1.36 on a closing basis with realized volatility expanding into the p20–p50 band. That signals capitulation of the orderly distribution phase and opens a path toward the 2024 low region (US$1.26) and potentially the 2019 base near US$1.02.

Liquidity is not the constraint — the tape is. For mid-sized fundamental funds, this is implementable size, but the right action today is watchlist, not build. If conviction returns on the fundamental side, accumulate slowly in US$0.6M–1.3M tranches against the US$1.57 reclaim signal; do not anticipate the reversal in front of the death cross.

---

Short Interest & Thesis — Yadea Group Holdings (1585.HK)

Figures converted from HKD at the prevailing HKD/USD peg of 7.80; reporting-currency CNY values converted at historical FX rates from data/company.json.fx_rates. Ratios, percentages, multiples, share counts, dates, and names are unchanged.

Bottom line. Official SFC reportable short interest in 1585.HK has rebuilt from a 17-month trough of 111.6M shares (10-Oct-2025) to 140.4M shares = US$212M as of 22-May-2026 — a +25.7% rebuild in seven months while the stock sat at the bottom decile of its 52-week range. At ~4.5% of shares outstanding, ~12% of approximate free float, and ~22 days to cover at 20-day ADV, the institutional short book is meaningfully sized, but no public short-seller report, activist campaign, or SFC/HKEX enforcement action has surfaced — the entire short thesis is private and circumstantial. The re-shorting cadence lines up precisely with the PwC → Deloitte mid-cycle auditor switch (Aug–Sep 2025), the death cross on 13-Nov-2025, and the forensic team's bills-payable / supplier-finance / CFO-quality red flags, suggesting at least one institutional desk has been adding under the same thesis the forensic page surfaces independently. Borrow-cost, utilization, and daily short-sale-turnover data were not available through this run's source channels; sub-threshold short positions and retail shorts are not captured.

1. Reported positioning trend — official SFC SPR

Three regimes visible since the start of 2025: (1) a heavy short book at ~160–180M shares through Jan–May 2025, which started covering in size after Yadea reported the FY2024 results in March 2025 and 1H 2025 trading update; (2) a 35% draw-down to 111.6M shares on 10-Oct-2025 — a 17-month low coincident with the Deloitte appointment (22-Sep-2025) and pre-empting the 1H 2025 interim print; (3) a steady rebuild from Oct-2025 to today, with shares short up 25.7% in seven months and now back at 140M, the highest level since mid-Q2 2025.

Position value tracks share count loosely but diverges in early 2026: short US$ value bottomed at US$173M on 30-Jan-2026 even though share count was only ~122M — that gap was driven by the price drawdown from ~US$1.92 in mid-2025 to ~US$1.42 in late January. As the price stabilised in Q2 2026, position value rose faster than share count, hitting US$212M on the latest print.

2. Crowding vs liquidity — the days-to-cover problem

The crowding signal is moderate but real. At 4.5% of total shares outstanding, the reportable book is below the threshold that historically triggers obvious short-squeeze dynamics in HK consumer names. But Yadea's effective float is depressed by the 62.96% DQ Prosperity Trust concentration — backing that out, reportable shorts represent ~12% of the float that actually trades, and there are ~22 sessions of 20-day ADV in the book. At thinner late-2024-style liquidity, that days-to-cover would extend further. For sizing, the constraint isn't whether the position can exist; it's how fast it could be unwound in a rally without paying through several days of average prints.

3. Short-thesis ledger — credible public allegations

No publicly disclosed short thesis exists for 1585.HK. The closest signal is the SFC SPR itself: someone (or several someones) above the reportable threshold has had a position of ~111–180M shares running for at least 17 months, rebuilt aggressively post-October 2025. They are not announcing their work. That makes the short book a risk indicator, not a vetted thesis — institutional positioning rather than a documented attack.

4. Where the short money may be signalling — overlap with forensic flags

Reading the SFC SPR rebuild alongside the forensic team's findings produces a coherent (but unproven) backdrop for the institutional short. The Forensic page graded this name "Elevated" (48/100) and surfaced three red flags. Each maps to a public event that aligns with the re-shorting trough-to-rebuild window.

The chain isn't a smoking gun. But the institutional short has rebuilt on the same calendar that produced the forensic team's evidence base, and the rebuild accelerated after both the Deloitte appointment and the INED departure announcement. The variant a long must be willing to take is: "the institutional short is wrong despite the auditor switch, the bills-payable book, the working-capital-led CFO, and the governance turnover." That is a defensible thesis — but the forensic page and the SPR trend should not be dismissed as independent.

5. Peer context — HKEX-listed Chinese auto / EV cohort

Yadea is mid-cohort in absolute short shares (140M) but small in US$ value (US$212M) versus the EV majors — the gap reflects market-cap difference, not lower crowding. Without standardised float and ADV across this set, % of float is not directly comparable; treat this purely as confirmation that 1585 is on the HKEX designated short-selling securities list and that institutional shorts trade it actively. The cohort context does not suggest Yadea is the most-shorted Chinese-mobility name on the HKEX — it confirms it is shorted in line with the auto and EV majors, with positioning trends that are stock-specific.

6. Borrow pressure and daily short-sale turnover — coverage gaps

The two gaps that materially affect institutional interpretation are borrow cost and daily short-sale turnover. The forensic-driven thesis (auditor switch + bills payable + CFO quality) is the type of allegation set that typically pushes borrow utilization above the structural background; that we cannot observe utilization is a real limitation. Daily short-sale turnover would let us see whether the rebuild since October-2025 was concentrated around specific catalyst windows (1H interim, FY2025 print, INED departure) or evenly distributed — that is a tape-quality question that the weekly SPR cannot fully answer.

7. Evidence quality

Decision framing for a PM. Three things change the read on this name. First, an institutional short of ~12% of float and ~22 days to cover is not screening-table noise — sizing and risk controls should account for both a documented covering catalyst and a documented confirmation catalyst on the 1H 2026 interim print (late August 2026). Second, the absence of a public short report is itself informative — it means the variant being expressed is in the SFC SPR rather than in writing, which lowers the public-narrative tail risk but raises the variant-perception risk. Third, HKEX SPR is partial; if total short interest (including sub-threshold and any retail synthetic short) is materially higher, the days-to-cover figure on this page is a floor.